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INTRODUCTION
Early studies concerning zinc, copper and iron
have emerged the essentiality of these metals to the
biological system (1,2). However the major impetus for
research was associated with trace mineral deficiencies or
toxicities. Most of our present knowledge, by the advent of
purified diets, could highlighten the significance of trace
mineral interactions. Such interactions may acknowledge the
importance of so pervading nutritional deficiencies or
toxicities in the biospheres especially in the developing
countries. However, the mode of action of suspected or
recognized trace element interactions remains, with few
exceptions, to be elucidated.
The effect of dietary zinc supplementation on
copper or iron biological availability, interactions, and
metabolism is controversial (3,4,5,6). Likewise, the
biochemical etiology of anorexia or growth retardation of
zinc deprivation is a matter of conjecture (7,8,9,10).
From the foregoing argument, it is apparent that
further study is required before a unifying hypothesis can
be established for the effects of interactions or imbalances
among zinc, copper and iron. Our study, therefore, will
assist in understanding of situations in which risk to
health exist from accumulation of potentially toxic
elements, and will facilitate examining metabolic
relationships between zinc, copper and iron to explain some
Vaspects of their mutually antagonistic effects. In more
practical spheres a more detailed knowledge of how such
interactions influence their availability will be of
increasing value in estimating dietary recommendations, in
establishment of new prophylactic measures and in assessment
of situations in which a substantial risk to human and
animal health in the developing countries may arise.
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ABSTRACT
Forty-two, male, weanling Sprague-Dawley rats
were divided into three groups of 14 rats each and pair-fed
a purified basal diet containing different zinc
concentrations for 8 weeks. Group C, was fed a control
purified basal diet containing 12 ppm zinc, 5 ppm copper and
3 5 ppm iron; group D was fed the basal diet containing <2
ppm zinc; group S was fed the basal diet supplemented with
1000 ppm zinc. The effects of the various dietary zinc
concentrations on growth rate, feed efficiency, blood
hemoglobin and hematocrit, relative organ weights, and
protein concentrations of tissues, and the zinc, copper and
iron content of blood, liver, kidney, spleen, heart and lung
were studied. Blood samples were collected at 2,4,6 and 8
weeks and tissues were sampled at 4 and 8 weeks. Rats fed
the zinc-deficient diet (D) had decreased weight gain and
showed signs of zinc deficiency at d 5, but polydipsia and
intermittent mild diarrhoea were also prominent and led to
dehydration. The decreased weight gain in these zinc-
deficient rats (D) suggest decreased protein synthesis may
be of zinc deficiency mediated decreased insulin activity. A
cyclical pattern of decreased and then normal food intake
and weight gain occurred in the zinc-supplemented rats (S)
from weeks 6 to 8 . Copper concentrations increased in heart
and lung by week 4, and decreased in liver and lung at week
58 in the rats of zinc-deficient diet (D) . In rats fed the
zinc-supplemented diet (S) , copper concentrations decreased
in liver and spleen and increased in kidney at week 4, and
decreased in the liver and increased in the heart by week 8.
Tissue iron concentrations in rats on the zinc-deficient
diet (D) were consistently increased in all tissues, except
liver, throughout the study. Rats receiving increased
dietary zinc (S) generally had depressed iron concentrations
in all tissues except heart. The fluctuations in tissues
element concentrations with increased duration of the study
is of variance with previous studies of shorter time frames.
These data suggest an inconsistent antagonism between copper
and zinc or other mechanisms may be involved in copper
homeostasis. If tissue concentrations reflect intestinal
uptake, an apparent competition and/or inhibition occurs
between iron and zinc in the intestine with zinc deficiency
but not in zinc supplementation. The relative dietary
proportions of zinc, copper and iron and time effect
influence zinc, copper and iron metabolism at the intestinal
and cellular transport level.
Keywords
:
Zinc, copper, iron, dietary element and interaction,
rats, zinc deficiency, zinc supplementation, weight gain,
feed efficiency, total protein, hemoglobin, hematocrit,
organ weight, tissue concentrations.
6INTRODUCTION
Early studies have been conducted to
elucidate the nutritional role of zinc, copper, and iron in
man and animals [1,2,3]. The role of zinc has been of
particular interest [4,5,6,7]. While these studies have
examined bioavailability, metabolism, deficiency and
toxicity of individual compounds, interactions between these
elements have been less studied.
The dietary essentiality of zinc for rats was
established more than 50 years ago [3], and the importance
of zinc in human and animal health [8,9] has been
thoroughly reviewed [10]. Dietary zinc could change
metabolism of other divalent cations [11]. However, the
effect of high dietary zinc on the utilization of copper is
controversial. Although zinc and copper exhibited mutual
antagonism at intestinal absorptive level [12,13,14], high
dietary zinc increased tissue concentrations of copper by
increasing metallothionein (MT) synthesis [6,15]. In
contrast, other investigators [5,7,16,17] demonstrated that
excess dietary zinc decreased the tissue concentrations of
copper.
Although decreased food intake and growth
inhibition are the only overt signs of zinc deficiency
[18,19,20], the mechanism of how the lack of zinc is
responsible is not known. Reduced food intake has been
corrected with zinc supplementation or by decreasing dietary
7proteins in zinc-deficient rats [18]. The anorexia of zinc
deficiency may be induced by abnormalities in endogenous
opiate regulation [21]. The growth inhibition seen in zinc
deficiency has been attributed to decreased food intake
[20,21,22], reduced feed conversion efficiency [23,24,25],
an inhibited secretion of growth hormone [26, 27], or poor
growth of skeletal muscles [19].
Anemia and reduced tissue iron concentrations
have been reported in mice, rats and chicks due to high
dietary zinc [7,28,29,30,31], but these have not been seen
in humans [32]. This inverse relationship between zinc and
iron has been rationalized by the hypothesis that zinc and
iron share a common absorptive pathway [29, 33], but other
studies have failed to demonstrate this [34]. Administration
of inorganic iron has depressed the absorption of inorganic
zinc, but not when zinc was in organic form [35,36] or given
with a meal [37]. Since the copper-dependent enzyme,
ceruloplasmin, has been shown to govern the rate at which Fe
(II) is released from liver ferritin, and is converted to
plasma transferrin-Fe (III) [38], zinc has been postulated
to alter iron metabolism by interfering with copper
metabolism [30,39,40,41,42].
Data on the interactions of zinc, copper and iron
vary with differences in diet formulations, relative dietary
ratios [5,7], the duration of study [7], and differing test
methodology. Accordingly, we designed an 8-week feeding
8study in which standardized test diets were used [43]. The
object of this study was to illuminate the metabolic lesions
of zinc deficiency and supplementation with special
reference to zinc, copper, and iron concentrations and
interactions organs and tissues of rats.
9MATERIALS AND METHODS
ANIMALS AND DIET:
Forty-two weanling , male, Sprague-Dawley rats
(Sasco Inc, Omaha, NE) were individually housed in stainless
steel, wire-bottomed cages and fed a standard rat diet
(Purina rat chow, St. Louis, MO) and allowed free choice
water during the acclimation period. The facilities
fulfilled the standards of the American Association for
Accreditation of Laboratory Animal Care. After 7 days of
acclimation the rats were randomly assigned to one of three
experimental dietary groups of 14 rats each and fed purified
basal diet (Purina Inc. , Richmond, Indiana) for 8 weeks that
vary only in the zinc concentrations (Table 1) . The basal
control diet (C) was formulated to contain 12 ug zinc/g, 35
ug iron/g and 5 ug copper/g. The zinc-deficient basal diet
(D) contained less than 2 ug zinc/g, while the zinc-
supplemented basal diet (S) contained 1000 ug zinc/g.
To ensure pair feeding, the rats were fed 15
g/rat/day for the 8 weeks till the termination of the
experiment. Free access toe deionized water was allowed
throughout the study. Food consumption was established by
measuring the unconsumed feed daily and body weights were
determined weekly. Our own analysis [44] verified that zinc
concentrations were 13-13.2, <2 ug zinc/g and 1000-1090, in
the control, zinc-deficient and zinc-supplemented diets
respectively. Copper and iron concentrations were constant
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at 5-7 and 35 ug/g respectively in each of the three diets.
SAMPLING AND ANALYSIS:
Heparinized whole blood samples were collected bi-
weekly for hemoglobin and hematocrit evaluation under mild
ether anaesthesia by cardiac puncture . At the end of the
fourth week, 5 animals/experimental group , selected at
random, were sacrificed by an overdose of ether anaesthesia.
Liver, kidney, spleen, heart and lung were excised , cleaned
of connective tissues, twice rinsed in deionized water, and
stored at -20 C for determination of zinc, copper, iron and
protein concentrations. The internal organ weights and mean
wet organ weight : body weight ratio were also determined.
This was repeated for the remaining rats at the end of the 8
-week feeding period.
A portion of the whole blood was analyzed for
hemoglobin and hematocrit by direct aspiration using an
automatic Coulter Counter (Model S-plus IV, Counter
Electronics Inc, Hialeah, FL) . The remaining whole blood as
well as the liver, kidney, spleen, heart and lung were
analyzed for zinc, copper and iron concentrations by atomic
absorption spectrophotometry [44].
The total protein content in liver, spleen, heart,
kidney, and lung was determined by the Bio-Rad protein
mircoassay method (BIO RAD, Richmond, Ca) . The standard
reference solution employed was bovine gamma globulin (1.29
mg/ml)
.
For the protein assay, 0.8 ml of standard,
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appropriately diluted samples and blanks were mixed with 0.2
ml of concentrated dye reagent and placed in clean ,dry test
tubes. Samples were vortexed and measured at 595 nm against
blanks using a Hitachi Perkin-Elmer (Tokyo, Japan)
spectrophotometer. Concentrations were then read directly
from a standard curve.
Tissues were prepared for elemental analysis by a
wet ash procedure. Using pre-washed forceps and scissors, 5
g of minced tissues with an equivalent amount of deionized
water homogenized in acid-washed tubes until a uniform
slurry was formed. One gram of slurry was then placed into a
tared 100 ml acid-washed beaker. Whole blood was prepared by
pipetting 1 ml of blood directly into a tared beaker. At
least two blanks were prepared using deionized water. Nine
milliliters of concentrated nitric acid (70-71%) was added
to each sample and allowed to digest overnight in an acid
hood. Perchloric acid (69-72%) was added the next morning to
establish a nitric:perchloric ratio of 9:2 or 9:1 for
tissues or blood respectively were gently heated. Small
increments of nitric acid were added as appropriate to avoid
tarring. Beakers were removed from heat prior to complete
dryness when about 0.1-0.2 ml of residual acid remained.
Appropriate amounts of 2% nitric acid in relation to tissue
weights were added and swirled to dissolve the digestion
residue. Beakers and ashed samples were weighed and the
samples transferred to an acid-washed polypropylene sample
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containers (25-30 ml size) . The sample zinc, copper and iron
concentrations were measured by atomic absorption
spectrophotometry with a Perkin-Elmer, Model 3 06 atomic
absorption spectrophotometer equipped with a one-slot burner
head, an acetylene flame, appropriate hollow-cathode lamp,
and recorder. Wavelengths used were 214 nm for zinc, 248 nm
for iron and 325 nm for copper. Standard reference solutions
for each element were purchased from Fisher Scientific
Company, Fairlawn.NJ.
Calculations for the element concentrations were
carried out using the following formulae:
Net weight of sample = (beaker + sample)
-
(tare weight
of beaker)
.
Net weight of ashed sample = (beaker + ashed sample)
-(
tare weight of beaker)
.
Wet ash dilution = (net weight ashed sample)/ (net
weight of sample)
.
Total dilution = (wet ash dilution) x (analysis
dilution)
.
Sample mineral (ppm) = (total dilution) x(ppm diluted
sample)
.
All data were statistically analyzed by analysis
of variance using SAS. Comparison between treatment means
was performed on the basis of the Fisher's LSD only when a
significant overall treatment effect was observed (F-test
,p<0.05) [45].
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RESULTS
Body Weight and Feed Efficiency:
Table 2 summarizes the body weight and feed
efficiency ratios of the rats fed the zinc-deficient (D) and
zinc-supplemented diets (s) for 8 weeks. Rats on the zinc-
deficient diet (D) were anorexic at the first week and,
although did not lose weight, thereafter they grew more
slowly than rats fed the control diet (C) or the zinc-
supplemented diets (s) . The mean body weight of rats fed a
zinc-deficient diet (d) was 79.7% and 77.8% of controls by
the end of week 4 and 8, respectively. That of zinc
supplemented group (S) was 101.9% and 97.8% of the controls
(Table 2) . Feed efficiency ( g of body weight gain/g of feed
consumed) was reduced for the zinc-deficient rats (D)
throughout the study, but was not significantly different in
the zinc-supplemented rats (S) when compared to the
controls. The signs manifested by the zinc-deficient group
(D) were anorexia, poor growth, rough coat, hyposthesia,
intermittent mild diarrhoea and polydipsia was also
prominent. Rats fed the zinc supplemented diet (S) showed no
signs of toxicity, but they lost weight during week 7. This
was compensated for during week 8 (Fig 1) .
Organ Weight:
At week 4 and 8 , the internal organ weights
(expressed as gram wet weight) of the zinc-deficient rats
(D) were significantly reduced in all organs except spleen
14
when compared to the paired-fed controls(C) (Table 3). In
contrast, no significant variation occurred in the zinc-
supplemented rats (S) , although liver and kidney weights
were slightly greater than in the controls at week 4 (Table
3) . At week 8 heart, spleen and lung weights of the zinc-
supplemented rats (S) were significantly less (p<0.05) and
than the paired-fed controls (C) (Table 3) . The mean
relative organ wet weight: body weight ( g wet tissue/g body
weight percent) of the zinc-deficient (D) and the zinc-
supplemented rats (S) was similar or greater than that of
control rats (C) (Table 4).
Hemoglobin and Hematocrit:
The rats on the zinc-deficient (D) , had increased
hemoglobin concentration . Zinc supplementation (S) had no
effect on hemoglobin concentrations when compared to
controls (C) (Fig 3) throughout the study.
The hematocrit was significantly increased in the
zinc-deficient (D) group (Fig 4) but no effect was observed
on hematocrit in the zinc supplemented group (S) during the
8-week course of the study.
Organ Protein Concentrations:
The protein concentrations (mg/g tissues) of the
organs at week 4 and week 8 decreased significantly (p<0.05)
in the zinc-deficient rats (D) but remained unchanged in the
lung at week 8 (Fig 2) . Similarly, protein concentrations
generally decreased significantly in the organs of the zinc-
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supplemented rats (S) , although they increased in the
kidneys at week 4 and showed no alteration in the heart and
lung at week 8 when compared to control organs (Fig 2)
.
Blood Element Concentrations:
The blood zinc, copper and iron concentrations at
weeks 2,4,6 and 8 are given in Table 8. Blood zinc
concentrations in the zinc-deficient group (D) were
decreased in weeks 2 and 8 , but not at weeks 6 and 8 . In
the zinc-supplemented group (S) blood zinc concentrations
were increased at week 2, were not significantly varied at
weeks 4 and 6 and were decreased significantly at week 8
when compared to the controls (C) (Table 8)
.
Blood copper concentrations were generally
unaffected by feeding the zinc-deficient (D) or zinc-
supplemented (S) diets, although reduced blood copper levels
occurred at weeks 6 and 8 in the zinc-deficient rats (8)
(Table 8)
.
Blood iron concentrations increased considerably
with a peak at week 6 in the rats fed the zinc-deficient
diet (D) , whereas in the rats given zinc supplementation (S)
the iron level was increased only at week 2 and remained at
control concentrations at the other weeks (Table 8)
.
Organ Zinc Concentrations:
Zinc concentrations in the heart and lung of rats
fed the deficient diet (D) were significantly lower than the
controls (C) and were similar of controls (C) in the
16
liver, spleen and kidney at week 4. However, a significant
decrease in zinc concentration was observed in all organs
except the heart at week 8 (Table 5) . Zinc concentrations
were higher than those of controls (p<0.05) in all organs of
rats fed the zinc-supplemented diet (S) , except for lung
and heart which were unaffected at the end of week 4 and 8,
respectively (Table 5) .
Organ Copper Concentrations:
At the end of the fourth week, copper
concentrations were significantly increased in heart and
lung and were not altered in liver , kidney and spleen of
the zinc-deficient rats (D) . At week 8 the copper
concentrations had decreased in the liver and lung and were
not different in the kidney, heart and spleen of the same
zinc-deficient (D) group (Table 6) . In the rats fed the
zinc-supplemented diet (S) copper concentrations were
decreased in liver and spleen, were increased in kidney and
were not altered in other of organs at week 4 . At week 8
copper concentrations in group S were decreased in liver,
increased in heart and were not changed in lung, kidney and
spleen (Table 6)
.
Organ Iron Concentrations:
In general , iron concentrations were significantly
increased in all the organs of the zinc-deficient rats (D)
,
however at week 4 liver had a lower concentration than the
controls and no deviation was observed in the kidney, and at
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week 8 liver and kidney were not different from controls
(Table 7) . Conversely, the iron concentrations in the major
organs of the zinc-supplemented rats (S) were generally
decreased, although no variation was detected from the
controls in kidney at week 4 and in the heart and spleen at
week 8 (Table 7) . Only the heart that had increased iron
concentrations at week 4 in the zinc-supplemented diet (S)
group.
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DISCUSSION
Body weight and feed efficiency in zinc-
supplemented rats (S) did not show significant difference
from controls (C) (Table 2) . Contrary to our observations,
other investigators reported increased [5,6] or decreased
[7,46] body weights concomitant with zinc supplementation.
Our data suggest that these differences may be explicable to
their short-term study or that our 1000 ppm zinc may not be
sufficiently toxic for such reactions to be emphasized.
However, the cyclical pattern in food intake and weight gain
expressed in the zinc-supplemented (S) rats in weeks 6-8
remained to be explained (Fig 1) . Rats fed the zinc-
deficient diet (D) exhibited signs of zinc deficiency as
reported in other studies [3,18,20,47], but inaddition
polydipsia and intermittent diarrhea were also prominent in
our study.
The organ protein contents displayed no
significant differences at week 4 and decreased afterwards
in the zinc-supplemented rats (S) than in pair-fed controls
(Fig 2) . This view is further strengthened by the
observation of similar responses in the internal organ
weights (Table 3) and body weights (Table 2) in the zinc-
supplemented (S) group. These data make it is difficult to
agree with other finding [6] that protein synthesis
increases with zinc supplementation. This may be due to the
use by the others [4,6] of experimental designs of shorter
19
duration which were not sufficient to produce effects we
have observed. The body weights (Table 2) , internal organ
weights (Table 3) and protein contents (Fig 2) of the rats
fed the zinc-deficient diets (D) were 20%, 19-38% and 13-22%
lower, respectively after the 8-week study than in the pair-
fed controls (C) . Whereas zinc deficiency has been
repeatedly described to have profound effect on growth,
speculations of mechanisms involved are associated with
marked change in appetite and food intake [18,20,22],
anorexia of abnormal opiate regulation [21], lower feed
conversion efficiency [23,24,25] or through inhibited
secretion of growth hormone (GH) at marginal (27] or severe
[26] zinc deficiency. However, the actual mechanism is not
well understood.
The results with proteins highlighted important
implications that zinc deficiency per se has a restrictive
effect on growth independent of reduction in food intake in
accord with previous studies (18,19). Further, zinc
deficiency has been shown to adversely influence the growth
of skeletal muscles as anabolic and catabolic phases of food
intake increases the overall energy requirements [19]. Since
our data (Table 4) emphasized that the mean organ weight:
body weight ratio was proportionally greater in the zinc-
deficient (D) than in the pair-fed controls (C),the
reduction in the body mass was greater as well. It has been
shown that zinc deficiency decreases insulin secretion
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indicated by high total insulinlike activity (TILA) [26].
Insulin is an important regulator of fuel metabolism by
promoting uptake of branched chain amino acids by muscles,
accelerates entry of glucose and fatty acids in muscles and
adipose cells and inhibits intracellular degradation of
proteins [48]. Abnormality of Insulin metabolism may,
therefore, contribute to decreased protein synthesis and
subsequently body weight loss. Thus growth inhibition
showed in the zinc-deficient rats (D) may has been mediated
,
inaddition to anorexia, via impairment of muscle protein
synthesis and asymmetry of total energy as result of
abnormality of insulin metabolism. Further investigation
will be required to clarify the biochemical etiology of the
poor growth and anorexia of zinc deficiency.
Fluid intakes decrease in zinc deficiency [8].
Diarrhoea of zinc deficiency may be directly associated with
zinc deficiency [49], increased fecal sodium losses [50] or
may be secondary to waned immunocompetence [51]. Polydipsia
and mild intermittent diarrhea were evident in rats fed our
zinc-deficient diet (D) , and resulted in increased
hematocrit values (Fig 4) suggesting hemoconcentration and
dehydration . These data find support in other reports
[9,47]. As proposed in other studies [52,53], osmotic
fragility of erythrocytes was not observed in the zinc-
deficient rats (D) since egg white was used as a source of
protein in the test diets and discoloration of plasma or
21
urine was not observed.
Although our dietary zinc level was strictly
deficient (< 2 ppm)
,
yet zinc retention was well restored in
organs at week 4 (Table 5) suggesting increased intestinal
absorption [54,55] or zinc resorption from tissues other
than internal organs. Chen et al [56] have speculated that
increased liver zinc concentration is attributable to
increased metallothionein (MT) in the liver soluble fraction
when rats fed 1000 or 2000 ppm zinc in the diet. Although
tissue zinc concentrations increased significantly (0-36%)
at week 4 , it then deceased significantly and consistently
in the liver of the zinc-supplemented rats (S) (Table 5) at
week 8 compared to the controls (C) . This suggests that
liver MT may not be the only factor for zinc accumulation in
the liver or that their effect may be exhibited on short-
term basis. This indicate that other (unknown) mechanism may
be involved in decreasing the uptake by the hepatocytes.
Furthermore, zinc concentrations were significantly
decreased in blood of the zinc-supplemented (S) rats at week
8 . An explanation for this reduction may be due to decreased
zinc flux consequent to increased intestinal thionein
binding. This has been reported elsewhere [57]. An
alternative interpretation could be increased zinc efflux as
part of homeostatic regulatory process of zinc excretion
[54,58]
.
Excess dietary zinc reduces copper absorption
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[7,14,16] via induction of MT synthesis in the mucosal cells
[17] or mutual antagonism at the absorptive site [13,59].
Other investigators [15], in contrast, reported induction of
MT synthesis with increased tissue copper concentrations.
Copper concentrations in our study were inconsistent in
organs (Table 6) or not altered in blood (Table 8) of rats
fed the zinc-supplemented (S) diets at weeks 4 and 8.
Likewise, copper concentrations significantly altered and
were inconsistent in various tissues of rats fed the zinc-
deficient diet (D) as determined at weeks 4 or 8 . It is
evident from our study that tissue copper concentrations
influenced with time and zinc dietary status. Furthermore,
irrespective of their luminal concentrations, the inverse
relationship between copper and zinc at the absorptive level
shown in other studies [13] is not always consistent with
time. Copper status therefore not only a reflect of mutual
antagonism between copper and zinc at the intestinal level
[13], but likely other mechanisms interfere with copper
metabolism at intestinal and/or cellular level.
The ingestion of excess zinc has caused anemia and
depressed hematocrit and reduced iron concentrations in
tissues of several animal species [18,29,30,39]. Iron and
zinc interactions are thought to be mediated via changes in
copper metabolism [30,38,39,40,41]. In our study, iron
retention was consistently depressed in all tissues except
heart (Table 7), and no change was observed on hemoglobin
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(Fig 3) , hematocrit (Fig 4) or blood iron concentration
(Table 8) in the zinc-supplemented rats (S) . Conversely,
tissue iron concentrations (except for liver) , blood iron
concentration, hematocrit and hemoglobin were significantly
increased in the rats on zinc-deficient diets (D) . Although
reported that zinc and iron are absorbed by different
metabolic pathways [34], other studies have reported inter-
element absorption competition [33,60]; zinc or iron
absorption is increased when the respective competitor is
deficient [39] in the diet . This suggests that these metals
may share part of the same intestinal absorptive mechanism.
Our findings support that competition between iron and zinc
at an absorptive level occurs, as documented by tissue
concentrations reflecting intestinal uptake [29,33,60,61].
The hematocrit, hemoglobin, and blood iron concentrations
resulting from dietary zinc supplementation suggest that
other mechanisms interfering with iron biological
utilization. In view that ceruloplasmin, a copper-containing
enzymes has been demonstrated to be involved in release and
conversion and incorporation of Fe(II) to Fe(III) in plasma
transferrin [38], zinc could influence iron metabolism by
interfering with copper metabolism.
Variations and conflict in conclusions from
studies involving interactions between zinc, copper and iron
would reflect not only differences in the relative ratios of
these elements in the test diets used but also the study
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duration during which such interactions are allowed to
become evident through the ways employed. Expert committee
should realize that the widespread occurrence of marginal or
impaired trace element nutrition in population at large may
lead to emergence of overt signs of deficiency in patients
who develop situations predisposing to that deficiency.
Future element interactions dietary experiments should
extent the time during which various dietary ratios are fed
to more closely approximate the long term dietary condition
that exists in various areas of this world's developing
countries.
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TABLE 1: INGREDIENTS OF THE BASAL DIET
USED IN THE CONTROL OF THIS STUDY.
INGREDIENTS AMOUNT (%)
Egg Whites 13.50
Sucrose 31.1995
Solka Floe 3.00
RP Vitamin Mix 2.00
Special Mineral Mix #2 5.00
DL-Methionine 0.10
Choline chloride 0.20
Biotin 0.0005
Corn Oil 2.5
Lard 2.5
Dextrin 40.00
Specifications:
Protein 12.15%
Fat 5.0%
Fiber 3%
Carbohydrates 73.2%
Digestible energy 3.86 Kcal/g
Iron 3 5 ppm
Copper 5 ppm
Zinc <2ppm for the deficient diet, 12ppm for the
control diet and 1000 ppm added as zinc carbonate
(0.1895%) for the zinc-supplemented diet.
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TABLE 2: BODY WEIGHT AND FEED EFFICIENCY IN GROUP OF
14 RATS EACH FED CONTROL (C) , ZINC-DEFICIENT (D) OR
ZINC-SUPPLEMENTED (S) DIETS FOR 8 WEEKS.
(Values are Mean ± SE,g)
GROUP BODY WEIGHT (g) % CONTROL F..EFFICIENCY
2
WKO WK4 WK8 WK4 WK8 WK4 WK8
C 85.8±2.53 209.7±2.9 a 261.5±4.1 a 0.31 0.21
D 88.7±2.5 166.2±2.7 b 199.7±3.7 b 79.7 77.8 0.23 0.17
S 90.4±2.5 212.5±2.6 a 256.2±3.5 a 101.9 97.8 0.31 0.20
Percent of body weight compared to controls.
2 Gram of body weight gain/g of food consumed.
3 Body weight within weeks that don't share a common
superscribt are significantly (p<0.05) different by
Fisher's LSD.
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TABLE 3: ORGAN WEIGHTS (g) OF RATS FED CONTROL (C),
ZINC-DEFICIENT (D) OR ZINC-SUPPLEMENTED (S) DIETS
FOR 8 WEEKS.
(Values are Mean Organ Wet Weight ± SE in g)
ORGAN/DIET WEEK 4 WEEK 8
LIVER
C 7.5 + 0.40 b 7.9 + 0.40 b
D 6.2 + 0.40 a 6.2 ± 0.40 3
S 8.4 + 0.40 b 8.0 ± 0.30
KIDNEY
C 0.7 + 0.03 b 0.9 ± 0.03 b
D 0.6 + 0.03 3 0.9 ± 0.03 3
S 0.8 + 0.03 b 0.8 ± 0.03 b
SPLEEN
C 0.5 + 0.04 3 0.6 ± 0.04 b
D 0.4 + 0.04 a 0.4 ± 0.03 a
S 0.4 + 0.03 a 0.5 ± 0.03 C
HEART
C 0.8 + 0.04 b 0.9 ± 0.04 b
D 0.6 ± 0.04 3 0.7 ± 0.03 a
S 0.8 + 0.04 b 0.7 ± 0.03 a
LUNG
C 1.3 + 0.10 b 1.3 + 0.10 b
D 0.9 + o.ioa 1.0 ± o.io a
S 1.1 ± 0.10b 1.1 ± o.io a
Means within a column for each organ with the same
superscript are not significantly different at the
0.05 level by Fisher's LSD.
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TABLE 4: MEAN ORGAN WEIGHT: BODY WEIGHT RATIO IN
RATS FED CONTROL (C) , ZINC-DEFICIENT (D) OR ZINC-
SUPPLEMENTED (S) DIETS FOR 8 WEEKS.
(Values are Mean ± SE in g/g percent)
ORGAN WEEK 4 WEEK 8
LIVER
C 3.6 ± 0.30 3.0 ± 0.30
D 3.9±0.50 3.0±0.30
S 4.0±0.20 3. 1+0. 30
KIDNEY
C 0.4±0.04 0.3±0.02
D 0.4 ± 0.03 0.3 ± 0.01
S 0.4±0.02 0.3±0.02
SPLEEN
C 0.2 ± 0.02 0.2 ± 0.02
D 0.3 ± 0. 10 0.3±0.02
S 0.2 ± 0.03 0.2 ± 0.02
HEART
C 0.4+0.02 0.3 ± 0.01
D 0.4+0.03 0.3 ± 0.03
S 0.3 ± 0.04 0.3 ± 0.02
LUNG
C 0.6±0.03 0.5 ± 0.10
D 0.5±0.04 0.5+0.10
S 0.5 ± 0.10 0.4 ± 0.01
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TABLE 5: CONCENTRATIONS OF ZINC (/ig/g WET TISSUE) IN
TISSUES OF RATS FED CONTROL (C) , ZINC-DEFICIENT (D)
OR ZINC-SUPPLEMENTED (S) DIETS FOR 8 WEEKS.
(Expressed as Mean ± SE in nq/q wet tissue)
ORGAN/DIET WEEK 4 WEEK 8
LIVER
C
S
KIDNEY
C
S
SPLEEN
C
S
HEART
C
22,,1 + 0,,9
a 26.,9 + 0,,8 b
19,.7 + 0.,9 a 22.,7 + ,7
a
24 .9 ± 1.,ob 24 ,7 + 0,,7 C
20,,1 ± 0.,6 a 19 .2 + 0, 5
b
18,,7 ± 0,,6
a 15.,3 + 0.,5
a
27,,3 ± 0,,7
b 22 .8 + 0.,5C
17,.4 ± 0,,6 b 18 .7 + 0,,5 b
19 4 ± 0.,6 a 17 .3 + 0.,5
a
19 ,7 ± 0.,6 a 20, , 1 + 0,,4
C
15,,6 ± 0,,9
b 15 ,2 + 0.,8 ab
18 .5 ± 0.,9 a 13.,6 + 0,,8
3
20.,7 ± 1 ,o a 17 ,5 + 0,,7
b
19,.3 ± 0,,5b 19.,1 + ,5
b
16 .0 + 0,,5 a 16,.9 + 0,,4 a
19,,0 + 0,,5b 21 ,0 + 0,,4C
S
LUNG
C
D
S
Means within a column for each organ with the same
superscript are not significantly different at the 0.05
level by Fisher's LSD.
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TABLE 6: CONCENTRATIONS OF COPPER (jig/g WET WEIGHT)
IN TISSUES OF RATS FED CONTROL (C) , ZINC-DEFICIENT
(D) OR ZINC-SUPPLEMENTED (S) DIETS FOR 8 WEEKS.
(Expressed as Mean ± SE in ixq/g wet tissue)
ORGAN/DIET WEEK 4 WEEK 8
LIVER
C
S
KIDNEY
C
S
SPLEEN
C
S
HEART
C
3 .3 + 0,,l
a 4 .3 + 0,,l
b
3 .6 + 0.,l
a 3 .6 + 0.,l a
2 .8 + 0,,lb 3 .4 + ,l a
4 .9 + ,5
a
5..7 + 0,,4
a
6 .1 + ,53 5 .4 + 0.,4 a
6 .4 + ,5 b 5,.8 + 0.,4 a
2 .2 ± 0.,l
a
1..4 + 0, I
a
2 .0 + 0.,i
a
1 .5 + 0. Ia
1 ,9 ± 0.,lb 1,,5 + 0.,l a
6,,7 + 0,,3
b
4,.6 + 0.,3
a
7,,7 ± 0,,3
a
4,,8 + 0. 2
a
6,.8 ± 0.,3
b
5.,4 + 0..2
b
2..1 ± 0. lb 1,,9 + 0. l
b
2..4 ± 0. l a 1.,5 + 0. l
a
2. 4 ± 0. l
b
1..9 ± 0. l
b
s
LUNG
C
D
S
Means within a column for each organ with the same
superscript are not significantly different at the 0.05
level by Fisher's LSD.
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TABLE 7: CONCENTRATIONS OF IRON (liq/q WET TISSUE) IN
TISSUES OF RATS FED CONTROL (C) , ZINC-DEFICIENT (D)
OR ZINC-SUPPLEMENTED (S) DIETS FOR 8 WEEKS.
(Expressed as Mean ± SE in M9/<J wet tissue)
ORGAN/DIET WEEK 4 WEEK 8
LIVER
C
D
210.8 ± 5.3 b
178.4 ± 5.3 a
193.3 ± 4.9 a
185.0 ± 4.5 a
S 165.8 ± 5.9 a 137.3 ± 4.2 b
KIDNEY
C 145.0 ± 4.1 a 157.9 + 3.7°
S 113.8 ± 4.5 b
SPLEEN
C 204.7 + 10.1°
S
HEART
C 87.7 ± 3.3° 68.6 ± 3 . b
S 109.0 + 3.6 65.0 ± 2 .
6
b
LUNG
C 93.6 ± 2.7 b 81.0 ± 2.7°
D
S
Means within a column of each organ with the same
superscript are not significantly different at the 0.05
level by Fisher's LSD.
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TABLE 8: WHOLE BLOOD ZINC, COPPER AND IRON
CONCENTRATIONS (ug/g WHOLE BLOOD) IN RATS FED
CONTROL (C)
,
ZINC-DEFICIENT (D) OR ZINC-
SUPPLEMENTED (S) DIETS FOR 8 WEEKS.
(Expressed as Meam+SE in ug/g whole blood)
ELEMENT WEEK 2 WEEK 4 WEEK 6 WEEK 8
ZINC
C 5.4 ± 0.3 b 4.9 ± 0.3 ab 5.6 ± 0.3° 5.9 ± 0.3 1-
S
COPPER
6.4 ± 0.3 C 5.5 ± 0.3
5.3 ± 0.3°
5.5 ± 0.3"
4.8 ± 0.3°
5.0 ± 0.2"
1.0 ± 0.04 u
0.8 ± 0.04°
0.8 ± 0.04 L
0.7 ± 0.03'
S
IRON
C
0.8 ± 0.03" O.i 0.04 0.9 ± 0.04' 0.8 ± 0.03'
516.9+15.2 698.5118.0 765.4+18.0" 556.1+16.4
329.1118.0"
755.4±18.0 U
577.1115.2"
543.5115.2°
Means within a column for each element with the same
superscript are not significantly different at the 0.05
level by Fisher's LSD.
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(1) Figure 1: Average weight gain (g)/week in rats fed
Control (c) , Zinc-Deficient (D) or Zinc-Supplemented (S) diets
for 8 weeks.
(2) Figure 2: Organ protein concentrations (mg/g) in rats fed
Control (C)
,
Zinc-Deficient (D) or Zinc-Supplemented (S) diets
for 8 weeks.
(3) Figure 3: Hemoglobin concentrations (g%) in rats fed
Control (C)
,
Zinc-Deficient (D) or Zinc-Supplemented (S) diets
for 8 weeks
.
(4) Figure 4: Hematocrit values (%) in rats fed Control (C)
,
Zinc-deficient (D) or Zinc-Supplemented (S) diets for 8 weeks.
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ORGAN ASSAYED AT WGK 4 OR 8
FIGURE 2
* Values for an organ are significantly different
from controls by Fisher's LSD (p<0.05).
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FIGURE 3
* Values for a week are significantly different
from controls by Fisher's LSD (p<0.05).
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FIGURE 4
* Values for a week are significantly different
from controls by Fisher's LSD (p<0.05).
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APPENDIX I
A REVIEW ON ZINC, COPPER AND IRON:
BIOCHEMICAL ROLES, METABOLISM, DEFICIENCY,
TOXICITY AND INTERACTIONS
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INTRODUCTION
The concern of trace elements in the biological
system began over a century ago. Early investigation
regarding iron, cell respiration and oxidative processes (1)
and nutritional role of zinc (2) founded most of the present
research understandings.
The advent of purified diets permitted a new
approach to study a wide range of naturally occurring
nutritional ailments in man and animals. The essentiality of
zinc (3) , copper and iron (4) for growth in rats has been
established 50 years ago. In 1950 's, it was evident that
either deficiencies or toxicities of certain minerals were
often precipitated by concurrent occurrence or absence of
other elements or nutrients in the environment. Such
nutritional interrelationships was shown by Dick (5) upon
investigating interactions of copper, molybdenum and
inorganic sulphate. These interactions may acknowledge the
importance of so pervading nutritional deficiencies or
toxicities in the environment. However, the extent of
possible dietary interactions and dietary forms of many
trace elements remain, with few exceptions, to be
elucidated.
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ZINC
ORIGIN:
Zinc has been utilized for industrial and
ornamental purposes for almost 2000 years, but its history
was obscured until the middle age era (2) . Early, zinc has
been shown to be a constituent (23%) of Semitic bronze (6)
and brass (2) and in formulation of a compound to the
Babylonians of 3000 B.C. (7) . The first revealed zinc piece
was in a form of idol (8) . Zinc has been thought to be the
component of several ores (8) . In Asia, zinc has been
introduced for utilitarian purposes since before (9) or
after the beginning of Christian era (10) . The laboratory
preparation of zinc metal was speculated to be practiced by
the Chinese (11) and Indians (12) in the twelfth century. It
has been thought that Meditteranians were the first to use
zinc ointment as curative remedy of skin lesions. However,
the first documented oral zinc therapy was the use of zinc
sulphate in treatment of gleet and leucorrhea (13)
.
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ESSENTIALITY AND REQUIREMENTS:
Zinc nutrition of man and animals has become an
area of intensive investigation. Early studies showed that
zinc is nutritionally essential for higher plants (14) and
animals (15) . Todd and associates (1934) , using semi
purified diets, had brought the first evidence that zinc is
essential dietary factor for rat growth (3). In 1955, Tucker
and Salmon (16) reported that zinc is a prophylactic and
curative remedy for parakeratosis in pigs. O'Dell and co-
workers (17) showed that zinc is a required nutrient for
growth, feathering and skeletal development in poultry. The
first evidence of zinc deficiency in man has been aroused by
Prasad and collaborates (18) . Subsequent studies identified
the severe acquired zinc deficiency syndrome (19).
Acrodermatitis enteropathica has been encountered in man due
to genetic zinc deficiency (20)
.
Quantitative assessment of dietary zinc
requirements have been determined in a number of animal
species. Zinc requirement for rat was estimated at 11-18 ppm
depending on protein source (21) . The minimum requirement
for growing rats has been estimated at 12 ppm on casein or
egg white diets (21) . Soybean diets significantly depressed
growth (22) and render zinc unavailable for rats due to
presence of high phytate content (21,23). Swenerton and
Hurley (24) reported that 60 ppm was inadequate and 100 pp
was adequate in preventing long-term testicular changes on
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diets containing soybean. Maximum growth in guinea pigs
necessitates presence of 12 ug dietary zinc added a casein-
based diet (25)
.
In female baby pigs, 45 ug/g zinc has been found
satisfactory for growth based on purified soybean protein
diets (26) , but 4 6 ug/g zinc improved growth rate in
weanling pigs (27) . Increments of dietary calcium to twice
normal or higher level required increase of zinc level well
above 45 ug/g to prevent signs of parakeratosis in pigs
(16,28). On a corn-based meal
,
35 ug/g zinc was shown to be
satisfactory for reproductive performance of breeding sows
(27) .
Lambs need 18 to 3 ug zinc/g egg white diets for
optimal growth (29) , and that 76 ug/ Kg body weight per day
was estimated as net requirement for maintenance (30) .
Underwood and Somers (31) suggested 17 ug dietary zinc for
convenient growth in rams, but it was not adequate for
testicular growth and spermatogenesis.
Dietary zinc of 8 to 9 ppm was found adequate for
growth in calves (32) , although 10 to 14 ppm is necessary to
maintain normal plasma zinc level (27). Intake of 2.65 mg
zinc per day was needed to maintain a 50 Kg calf (33) . On
the basis of minimal urinary, fecal and body surface losses,
Weigand and Kirchgessner (34) assigned 53 ug/Kg body weight
a daily net zinc requirement for maintenance of lactating
cows.
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Chicks grew well on 35 to 40 ug zinc/g soybean
protein-type diets (17) , and 25 to 30 ug/g on animal protein
source (35) . Monkeys require 15 ug dietary zinc for optimal
growth (36)
.
Estimates for human needs have been derived from
metabolic balance studies (37) and regression analysis of
apparent zinc absorption and retention (38) . The
bioavailability of zinc from various sources was determined
at 20% in terms of fractional absorption (39) . In one study,
adult human diets has been shown to supply from 5 to 2 2 mg
zinc per day (40) , but most mixed diets provide 12 to 15
mg/day (41) . A balance study in healthy adults receiving Il-
ls mg zinc/day had shown adequacy or slight positive
response (42) . An experimental study of zinc deficiency had
suggested minimal endogenous losses of zinc to be 146 mg via
feces and urine and 0.81 via integument (43)
.
Turnland and associates (44) suggested that 15 mg
dietary zinc is adequate for elderly males, but it was also
estimated at 8.8 mg zinc/day (45). A remarkable retention of
zinc was observed in preadolescent children receiving 6 to
18 mg zinc/day (46) . In preadolescent girls (47) 6 mg zinc
per day was shown to be adequate, but Richie et al (48)
suggested 7 to 8 mg/day. Based on zinc balance studies (49)
and assuming 30 ug zinc/g of fat free tissues, zinc is
required at approximately 150 ug/Kg body weight or a total
of 725 ug/day for normal growth in infants between 1 and 3
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months; 67 ug/Kg body weight for 3 to 6 months; 40 ug/Kg
body weight for 6 to 9 months and 25 ug/Kg body weight for 9
to 12 months (27)
.
Zinc balance during the third trimester of
pregnancy was determined by Swanson and collaborates (51) .
That zinc is daily retained primarily in the placenta during
the last 20 weeks of gestation has been hypothesized by
Sandstead (52,53). Zinc requirements and retention was
difficult to achieve in preterm infants (50)
.
Zinc content of some forages and animal foods has
been comprehensively reported (45,55). White sugar, pome and
citrus provide negligible proportions of zinc in the diet
(56) . Wheat germ bran and oysters are among the richest
sources (56)
.
Canned vegetables has been reported to contain
40 to 80% less zinc than fresh vegetables (57) . Zinc
contents of cow's milk vary from 3 to 8 ug/g (58,59). The
bioavailability of zinc varies considerably with percentage
absorption (60,61) and type of meal consumed (61).
The recommended daily allowance is 3 mg for
infants less than 6 months of age, 5 mg for older infants,
10 mg for preadolescent children, 15 mg for adolescents and
adults, 2 mg during pregnancy and 25 mg during lactation
(62).
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CHEMISTRY
Zinc is a bluish-white metal with a density of
7.133 g/cc. Its atomic number is 30, atomic weight is 65.37
and it is placed in group lib of the periodic table. Zinc is
a divalent element (2 + ) with electron configuration of 2-8-
18-2. Zinc is derived from zinc blende (sphalerite) and
marmatite, which are zinc sulphide ores. The former
constitute about 90% of our today's metallic zinc. Zinc
exists in hydrated form in neutral and acidic aqueous
solutions, but the hydroxide is precipitated in alkaline
solution. Zinc compounds possess chemical properties that
make them useful as oxides, carbonates, sulphides,
phosphates, chlorides and organic complexes. Because of its
known electrochemical activity, zinc is utilized in
galvanizing iron and steel to protect against their
structural degradation. zinc readily forms an alloy with
other metals. Zinc oxide is commonly used in paints and in
vulcanization of rubber. Other useful zinc inorganic
compounds include; zinc sulphate, zinc chloride, zinc
sulphide, zinc carbonate, zinc borate, zinc cyanide, zinc
nitrate, zinc phosphate, zinc permangenate and zinc peroxide
(56).
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BIOCHEMISTRY
Since the essentiality of zinc as a growth factor
has been determined (15,63), it is obvious that the element
is involved in various metabolic processes leading to normal
development. Zinc has been found to be incorporated in over
70 metal loenzymes (64) , which have significant metabolic
roles. Moreover, zinc is apparently required to maintain the
structure of apoenymes (64) .
The first biological function of zinc was
determined by Keilin and Mann (65) on isolation of carbonic
anhydrase (EC 2.2.1.1) from bovine erythrocytes. Three forms
of carbonic anhydrase have been identified (66) , in which
zinc is tightly bound to the active site (67) to potentiate
its catalytic activity (68) . This enzyme plays an important
role in rapid dehydration of bicarbonate in lung and
hydration of carbon dioxide in other tissues (69) . The metal
has been shown as a constituent of alcohol dehydrogenase (EC
1.1.1.1.) of microorganisms, peanuts and mammalian liver
(70,71). Using NAD as a co-factor, dehydrogenase canalizes
the oxidation of ethanol, vitamin A and certain steroids,
and that it reduces aldehydes and ketones in the presence of
NADH (71,72). Carboxypeptidases are zinc metalloenzymes
catalyzing the hydrolysis of c-terminal peptide bonds of
peptides and proteins (73). Carboxypeptidase A (EC 3.4.2.1.)
isolated from beef pancreatic glands (74) is known to
contain one gram of zinc per molecular weight of 34.600
56
(75). Carboypeptidase B (EC 3.4.2.2.) of the pancreatic
secretion (76,77) contains one gram of zinc per molecular
weight of 34.300 (12). Alkaline phosphates (EC 3.1.3.1.), a
zinc metalloenzyme (78,79) of E.Coli (80) has been shown to
contain 4 atoms of zinc which are necessary for activity and
structural integrity of the enzyme (81) . Alkaline phosphate
catalyzes the hydrolysis of a variety of phosphate esters
including; B-glycerophosphate (82), paranitrophenylphosphate
(53), and phenol-phthalein monophosphate (84).
That zinc is required for DNA synthesis was
demonstrated by Buchanan and Hus (85) . Further, zinc
deficiency has been reported to influence adversely the cell
1 2cycle phases (G ,S,G and mitosis) of Euglena gracilis (64)
indicating the vital role of zinc in DNA synthesis (86) . The
inhibitory effect of EDTA on activity of DNA polymerase (87)
and DNA transferase (88) provided further proof suggesting
that a protein bound metal atom is required for enzyme
activity. Some investigators (86) suggested that the
decreased activity of deoxythimidine may be responsible for
the initial depression of DNA synthesis. Three nucleotide
polymerases have been identified as zinc-dependent enzymes;
DNA polymerase (EC 2.7.7.7.) containing 2 to 4 gram atom of
zinc per mole (89) ; DNA dependent RNA polymerase (EC
2.7.7.6.), containing 2 gram of zinc per mole (90); and DNA
dependent DNA polymerase (91) . Other zinc-dependent enzymes
include; dehydropeptidase, aminopeptidase, enolase,
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arginase, tripeptidase, histidine deaminase and L-
Mannosidase (92). Sanstead et al (93) provide evidence that
zinc play a role in the maintenance of poly nucleotide
conformation.
On a fat-free basis, total body zinc
concentrations has been found to be 2 to 3 ug/g in rat,
cat and pig (94) , and cow (95) and sheep (96) . Large
proportions (50-60%) of zinc are confined to highly
oxidative (97) muscles of humans (2) and lactating cows
(98) . In bones and integument, zinc concentrations have been
estimated at 100-250 ug/g (99) , and 20 ug/g (96) on dry
weight basis. Only less than 0.5% of total body zinc is
found in blood of adult human (2) or sheep (96) of which 75-
80% in the red cells and 12-22% in plasma (27)
.
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METABOLISM
ABSORPTION :
The mechanism and control of zinc absorption
are still difficult to comprehend, however it appears that
zinc absorption is influenced by a number of environmental
factors (100) . The percentage absorption of zinc has been
demonstrated to be 5 to 10% in rats (101) , 20 to 30% in
growing chicks (102) and 50.8% in humans (103). In rat, a
number of studies have determined the major sites of zinc
absorption to be the duodenum, jejunum and ileum
(104,105,106). Davies and associates (22) indicated that
zinc absorption is 60% from duodenum, 3 0% from ileum and 10%
from jejunum in fasted rats, but Antoson et al (107)
reported 60% from the ileum and 20% from both jejunum and
duodenum in none fasting rats. It has been shown that zinc
uptake by rat duodenum is saturable at lumen zinc level of
0.8 mM (104), but another study (108) suggested a lower
level of 100 uM with maximum absorption capacity at 7.4
nmol/min. One third of oral zinc dose is absorbed in the
abomasum of cattle (109) . Zinc absorption was greatest in
the distal and proximal ends of the intestines of calves
(110)
.
In chicks, proventriculus and small intestine
constitute the major routes for zinc absorption (111).
Cousins (112) has proposed 4 phases for zinc
absorption; uptake by the intestinal cells, transfer through
mucosal cells, entry to the portal circulation and re-
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secretion of zinc intestinal cells. Citrate, picolinate,
histidine, glutamate and ethylenediaminetetraacetic acid
(EDTA) were experimentally suspected to facilitate zinc
absorption as binding ligands (113,114,115), yet the exact
physiological role remains to be elucidated. Suso and
Edwards (102) suggested that presence of chelating agents in
the ingested food enhance zinc absorption from the gut. Hahn
and associates (116) demonstrated that N-N-N-trimethyl-1, 2-
ethandiamine is zinc-binding ligand in swine duodenum.
Subsequent studies (117) reported that prostaglandin E,
plays an important role in zinc binding and transport across
the intestinal mucosa. Zinc absorption decreased with
dietary phytate (23), high phosphate level (118) or excess
dietary calcium (119), and increases in the presence of
certain amino acids, peptides or EDTA (120). It has been
shown that coffee, dairy products and brown bread have
tendency to reduce zinc absorption in humans (121)
.
There is inverse relationship between
metallothionein synthesis and zinc absorption (122) . About
20 to 30% of cytosol zinc is confined to metallothionein
fraction (123), and that it contributes to zinc homeostasis
between lumen and portal circulation by retarding zinc
transfer from the cell (112) . Transfer of zinc from cell to
portal circulation has been found sluggish when compared to
the uptake process in rat (104,124).
Zinc supply status contributes greatly to overall
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zinc homeostasis (125,126). However, Solomons and Cousins
(100) suggested that high circulatory zinc, by inducing
intestinal metallothionein synthesis, enhances mucosal zinc
to accumulate both dietary and endogenous zinc contributing
to zinc homeostasis. Physiological factors such as age
(127)
,
pregnancy and lactation (27) were reported to have
influential effects on the level of zinc absorption.
INTERMEDIARY METABOLISM:
The absorbed zinc will be bound to albumin (128)
,
of which 30 to 40% will be liberated to the circulation
(129) with subsequent distribution to other tissues at
various concentrations and turnover rates (129,130). It has
been shown that alpha-macroglobulin, transferrin,
ceruloplasmin, hepatoglobin and gamma globulin also bind
significant amounts of zinc (93). A small amount of zinc
exist as an ultrafiltrable fraction mostly bound to amino
acids histidine, glutamine, threonine, cystine and lysine
(93) . Circulating zinc will also be pooled into red blood
corpuscles and soft tissues rather than to be excreted (61).
Intraperitoneal injection of zinc had affected both zinc
turnover and distribution (27), but other studies (131)
reported that zinc retention is enhanced and turnover is
decreased in soft tissues and organs except bones and with
restricted dietary diets.
The uptake of zinc by cells involve rapid
61
saturable uptake process which may be carrier mediated
followed by slower phase that is apparently passive
(132,133). Furthermore, increased uptake may be stimulated
via glucocorticoides with excess quantities being bound to
newly synthesized metallothionein (134) . About 60 to 80% of
intracellular zinc occur in cytosol, 10% in the nuclear
portion and only small amounts in the mitochondria and
ribosomes (135,136). However, there is evidence that most of
cytosol zinc is bound to protein (123,137), while few or
surplus amounts are bound to metallothionein under normal
(138) or increased (137,139) zinc dietary states,
respectively. This suggest that metallothionein has a
complementary role particularly in hepatic zinc metabolism
(140,141). Liver cytosol has been reported as a major
compartment for zinc metabolism in rats (123), chicks (137),
cattle (139) and humans (132), and that it provides
necessary zinc binding components in amounts and proportions
coinciding with zinc status and age of the animal (142).
Zinc appears to play an important role in inducing
synthesis of metallothionein mRNA (143,144). In its bound
form, zinc is an essential factor in maintaining the
configuration of RNA (147), DNA (148), ribosomes (149) and
biomembranes (150)
. Glucocorticoides (145) and
catecholamines (146) indirectly stimulate metallothionein
synthesis probably by potentiating zinc entry into hepatic
cells.
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EXCRETION :
Under normal dietary circumstances feces
constitute the major route for zinc excretion
(45,151,152,153), however 2 to 10% may be recovered in
urine. Fecal excretion included both unabsorbed dietary
zinc and endogenous fecal excretion of zinc, a primary
mechanism for zinc homeostasis (129,154). Endogenous fecal
excretion of zinc has been demonstrated to increase with
increased dietary zinc (155) , and to decrease on low zinc
diets (27) . Biliary, pancreatic and mucosal cell routes have
been demonstrated to be the major sources for endogenous
fecal excretion of zinc (122,156,157). Urinary excretion of
zinc was estimated at 300 to 500 ug/day in adults (158,159),
380 ug/day in preadolescent children (48) and approximately
187 ug/day in young children (160) . Urinary excretion of
zinc was less than 1 mg/day in sheep and calves and
approximately 0.25 ug/ml in dairy cows (27). Urinary zinc is
a function of filtration of plasma zinc (161) , rate of urine
production and amounts of creatinine excreted (162,163).
Dermal and sweat zinc losses (43,164), and menstrual losses
(165) were reported as minor excretory routes of zinc.
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ZINC DEFICIENCY
Only a few cases of frank zinc deficiency
have been reported in cattle (2) and sheep (166). Using
experimental poor zinc diets, primary zinc deficiency has
been demonstrated in man (167,168). Conditioned zinc
deficiency is characterized by hypogonadism and nutritional
dwarfism in man (169) , which could be ameliorated on zinc
supplementation (170,171). Conditioned zinc deficiency may a
sequel to excessive renal (172) and intestinal (173)
excretion and to increased requirements in neoplastic
diseases (174,175), burns (176) and pregnancy (175).
Food consumption is significantly reduced in man
and animals with zinc deficiency (177) . Food consumption is
variable (178,179), and that it less affected when rats fed
a 5% rather than 20% protein diet. Dietary intakes is
increased following zinc repletion in zinc-deficient rats
(180).
Growth retardation is an overt feature in all
species showing signs of zinc deficiency including rats
(179,181), lambs and calves (32) and fetuses (182). Growth
inhibition may be associated with decreased thymidine kinase
activity with subsequent depression in DNA synthesis and
cell division (178,183). Other possible causes for growth
retardation may include abnormalities of endogenous opiates
regulation (183), increased protein catabolism (184),
hypogeusia (185) and decreased levels of growth hormone
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(186) . Moreover, anorexia nervosa of humans has been
attributed to zinc deficiency (187) . Skeletal deformities
due to zinc deficiency have been demonstrated in chicks,
poults and quail (17,188). Thickening and shortening of
bones (27) , stiffness of joints in calves (189) and sheep
(166), and skeletal malformations in rats (182) were
observed on feeding zinc depleted diets.
There was evidence of relationship between
subnormal hair and plasma zinc levels and the incidence of
atherosclerosis and myocardial infarctions (190,191),
however the mode of action awaits explanation. Although zinc
therapy has been shown to be beneficial in curing chronic
leg ulcerations (192) and bed sores (193), the effect of
zinc on wound healing is a matter of conjecture (194)
.
Erythrocyte counts and hematocrits of rats (19 5) and
Japanese quail (188) increased and leukocytes of baby pigs
(27) decreased with dietary zinc deficiency. Increased
osmotic fragility is a feature encountered in erythrocytes
of zinc-deficient rats (196) . Some studies (197) reported a
drop in plasma protein levels, but others (188) did not.
Deficient plasma zinc levels have been reported in acute and
chronic infections (198) , in uncured pernicious anemia (199)
and in cirrhosis and liver diseases (200)
.
Impaired DNA synthesis in the liver of zinc-
deficient rat has been demonstrated in many studies
(201,202). The testes contents of zinc, total proteins, DNA,
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and RNA were shown to be reduced in zinc deficiency (203) .
Zinc is necessary for regulation of cell mitosis (204) , and
that protein synthesis is impaired in zinc deficiency (205)
possibly as a consequence of abnormally produced or
inhibited ribonucleic acid synthesis.
Thymidine kinase activity, an enzyme required for
DNA synthesis and mitotic division of cell (86) and
pancreatic carboxypeptidase activity (195) have been found
to be depressed in tissues of zinc-deficient rats. Subnormal
levels of alkaline phosphatase were encountered in tissues
of zinc-deficient calves (206)
,
pigs (207) , rats (208) and
man (209)
.
Similar alterations were obtained with carbonic
anhydrase levels in the blood of zinc-deficient calves
(210) , rats (211) and dwarfs (40) . Zinc-dependent enzymes
including lactic dehydrogenase (LDH) , malic dehydrogenase
(MDH)
,
and NADH levels were reduced in testes, bones,
oesophagus and kidneys of zinc-deficient rats (212) and baby
pigs (213).
Dark adaptation (214), protein metabolism and
uptake (215,216), and insulin metabolism (217,218) were
found to be adversely affected in zinc-deficient rats. An
appreciable alterations in carbohydrate metabolism and
adipose tissues were revealed in zinc deficiency (219), but
Quarterman and Florence (220) found that these changes are
modified with feeding patterns. The composition of essential
fatty acids is adversely affected by zinc deficiency (221)
.
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Hyperkeratinization and dermatitis (27)
,
parakeratosis (31) and poor feathering (17) are clinical
manifestations of zinc deficiency in animals and birds.
Diarrhoea has been shown in zinc deficiency (20) with
subsequent losses in sodium and potassium (222) . Zinc
deficiency could induce immunosuppression in monkeys (223)
guinea pigs (224) , mice (225) and man (226) . Spermatogenesis
and development of secondary sex organs were shown to be
adversely affected by zinc deficiency (31,227).
Acrodermatitis enteropathica (20) and pancreatic
insufficiency (228) have been implicated in the development
of malabsorption syndrome in man. Hypogeusia (185) , impaired
healing (229,230), ischemic leg ulcerations (231) and sickle
cell disease (232) are yet other consequences of chronic
zinc deficiency.
Brain function and maturation are adversely
affected during embryonal life (203) , early childhood (233)
and early adolescence in monkeys (223) . Deleterious effects
encountered in offspring's learning abilities when born to
dams deficient in zinc (234). In uncured acromegaly, zinc
levels were considerably lower compared to controls (235).
Behavioral abnormalities are associated with zinc deficiency
(236) and could be alleviated wit^h zinc supplementation
(237).
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ZINC TOXICITY
Zinc is generally a none toxic element to mammals
and birds, however toxicities have been demonstrated in a
number of species due to oral, parenteral or environmental
exposures (238,239). Natural or accidental zinc poisoning
has been reported in sheep and calves (238) as well as dogs
(240) . In young animals, an intake of 5000 ug/g zinc oxide
has resulted in growth retardation concomitant with high
mortality rates, while less severe effects were encountered
with a lesser dose (241)
.
Ruminants are more susceptible to zinc toxicity
as compared to other species probably due to ill-effects on
microorganisms (2), volatile acid concentrations (241) or
cellulose digestion in the rumen (242). Although zinc
supplementation reduced plasma copper concentrations to
levels indicative of deficiency (243), it has been revealed
beneficial in improving hemoglobin
, RBC, cell volume and
total protein level of cattle (244) . High dietary zinc (1700
ug/g) induced signs of deprived appetite, depressed weight
gain and feed efficiency in steers and heifers (245) , but
increased tissue concentration of zinc and iron and
decreased liver copper concentrations ( 238)
.
Iron and zinc concentrations in liver and kidney
of chronic zinc-poisoned sheep and calves (500-1000 ug/g)
were significantly elevated with no significant alterations
in copper contents (238) . Similar alterations were observed
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in weanling lambs receiving 1500 ug/g diet (241) . However,
Davies and co-workers (246) observed, in addition, extensive
renal damage in suckling lambs on feeding 134 ug/g diet.
Moreover, Bires (247) showed that blood levels of zinc and
copper remained high following parenteral administration of
copper oxide in sheep. Pregnant sheep showed high incidence
of abortion and stillbirths when fed 750 ug zinc/g diet
(245)
.
The clinical manifestation of copper intoxication in
sheep was described as inappetence, loss of condition,
diarrhoea, profound weakness, icterus and anemia (238)
.
Kidney is the most affected organ in experimental zinc
toxicity of sheep (248) with high zinc concentrations in
liver and pancreas (248,249).
Decreased hematocrit (250) , anorexia (251)
,
microcytic hypochromic anemia (252,253), reduced copper
concentrations (253), growth retardation (254,255) have been
reported in rats receiving excess zinc intakes. However,
increased or unchanged copper concentrations (254,255) and
increased weight gain (254) were also reported. Other
studies claimed that hemoglobin and growth rate (256) and
copper levels (255) remained unchanged in rats fed high
dietary zinc. A decrease in iron concentrations was observed
in some studies (250,253) especially in liver (255,256) and
kidneys (255) in rats fed zinc supplemented diets. Zinc
concentrations were high in all tissues except liver, heart
and lung of rats (254). Conversely
, zinc concentrations
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were high in heart
, liver , kidney and spleen of zinc-
supplemented rats (187) . An appreciable drop in cytochrome
oxidase activity (251) and increased prostaglandin activity
(257) were also reported in rats fed high levels of zinc.
Richard and co-workers (258) described a
combination of zinc toxicity, copper deficiency and anemia in
swill-fed pigs. Pigs were tolerant to 500 ug zinc/g diet
(259,260), but levels of 5000 ug/g have resulted in
increased zinc and decreased copper concentrations in plasma
and liver (261). In another study (262), a level 1000 ug
zinc/g diet revealed no ill-effects in weanling pigs, but
Brink and associates (263) have reported reductions in
weight gain, feed intake and feed efficiency, arthritis and
gastritis in weanling pigs when fed 2000, 4000 or 8000 ug
zinc/g diet.
No significant effect observed in hemoglobin,
hematocrit, glucose, BUN, total proteins and enzymes of
monkeys fed high dietary zinc (264) . However, hypocupremia
and hyperchlestrolemia were observed in female monkeys fed a
zinc-supplemented diet (264) . In humans, oral zinc did not
produce ill-effects
, however acute and chronic toxicities
were reported with gastrointestinal disorders as main
features (2)
.
Moreover, hypocupremia has been shown in
patients with acrodermatitis enteropathica (265) or sickle
cell anemia (93) receiving zinc therapy.
Excess dietary zinc has been proposed to prevent
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copper intoxication since it alleviated copper accumulation
in the liver when added to high copper diets (266,267).
Other investigators suggested that a mutual antagonism
between zinc and copper is expressed when luminal
concentration of the respective congener is increased
(268,269). It has been suggested that high dietary zinc
exerts its antagonistic effect by potentiating the synthesis
of copper-binding ligand, probably metallothionein, thus
reducing its absorption and bioavailability to tissues
(270) . Cox and Harris (253) reported that excess dietary
zinc produces an early and marked loss of hepatic iron and
copper and showed that zinc does not interfere with iron
absorption. Conversely, Settlemire and Martone (271)
indicated such interference at the absorptive level.
Elevation of dietary calcium level from 0.7 to 1.1% was
proved to effective in protecting against high dietary zinc
levels (272)
.
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COPPER
ORIGIN:
Copper has long been recognized to be
essential factor for growth and development of living
matter. Over 2000 years ago, Hindu, Egyptian and Assyrian
alchemists have prescribed copper and its compounds as a
remedial therapy for many human maladies (92) . Early, copper
was found to be incorporated at 7% in turacin (273), a red
porphyrin of certain bird feathers and in hemocyanin, a
blood component of certain snails (274) . That copper is
essential element in rats was first reported by McHargue
(275) and Hart (4). In 1937, Bennetts (276) described
nutritional disorders of copper in lambs, enzootic neonatal
ataxia, when borned to copper-deficient ewes in Australia.
In early 1950's (5), the existence of the three-way
interaction between copper, molybdenum and inorganic
sulphate has been emphasized.
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ESSENTIALITY AND REQUIREMENTS:
The essentiality of copper has been reported as
early as 1817 (92), which then paved the way for the study
in different animal species. The growth-stimulating effect
of copper is not fully understood ,but it is partially
described in some studies (277) . Discrepancies regarding
responses to supplementary copper is attributable to mutual
antagonism between iron and copper, copper and zinc (270)
or calcium, zinc and copper (278)
.
A supplement of 0.005 ug Cu/day improved growth
and hemoglobin concentrations in rats fed milk diets (279)
.
The minimum reguirement for a 70-gram rat fed a 10 gram diet
daily was proposed at 1 ppm for hemoglobin production, 3ppm
for growth and lOppm for melanin production in hair (56) .
Copper deficiency developed in rats when fed <1 ug Cu/g diet
(270) . An amount of 5 ppm has been recommended as adequate
nutrient requirement for growth, gestation or lactation in
rat (280)
.
However, the minimum requirement for maintenance
remains to be elucidated (280) . Kirchgessner and Spoerl
(281)
,
however, showed that 8 ug Cu/g starch-casein based
diet is required for pregnancy and lactation in rat. Anemia,
hair depigmentation and stunted growth were expressed in
guinea pigs fed diets containing 0.5-0.7 ppm copper (282).
Ullery and co-workers (283) observed no
significant differences in treatments when baby pigs were
fed diets providing 6,16 or 106 ppm copper. Copper levels of
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4 ug/g copper was proposed adequate for growth in pigs up to
90 Kg live weight (270) . Addition of 250 ug/g copper to
normal pig rations improved weight gain of growing pigs
(284) and that daily weight gain and feed efficiency
increased by 8% and 5.5%, respectively (285). Another study
reported average increase of 9.7% in weight gain and 7.9%
increase in feed efficiency (286) . Adverse effects
manifested by reduced live weight gain and feed efficiency
(266) mortality and skin lesions (305) were also observed in
animals fed added 250 ug/gm copper sulphate.
Few data available describing the minimum copper
requirement for growth and production in poultry. However,
4-5 ug/g copper is found adequate since other antagonistic
elements are meager (287) . A positive input was observed at
levels of 75 and 225 ug/g copper, but levels of 300 ug/g
inhibited growth in poultry (270) . A level of 100 ug/g
copper improved weight gain of 9-week old chick and duckling
8-63 days of age (288) . A supplementary copper of 250 ug/g
improved chick growth on fish meal, wheat and added tallow-
based diet, whereas no response or depressed growth observed
when copper was added to a maize-soybean diet (270)
.
Cross-bred sheep were found to be well maintained
at intakes of 1 mg Cu/day (289). Nonetheless, copper levels
of % mg/day was found to be insufficient to merino sheep,
and that 10 mg/day or 10 ug/g was shown to be satisfactory
(290). Dick (5) described that molybdenum intakes of 0.5
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mg/day can induce antagonistic effect in copper retention in
sheep. However, Suttle (291) indicated that such effect is
insignificant. Parenteral administration of 30-40 mg copper
glycenate or CuCaedtate has been found satisfactory in sheep
(292) , if given at intervals of 3-6 months. Another study
showed that a single dose of 4 0-60 mg copper glycinate,
methionate or CuCaedetate is adequate in pregnant ewes
(293) . however, death was reported in ewes injected
parenterally with copper compounds (294).
Cattle grazing in pastures providing 7-14 ug/g
copper and 3-2 ug/g molybdenum developed copper deficiency
(295). Salt licks containing 0.5 -1.0% copper sulphate or
5-7 Kg/hectare of copper have been found satisfactory to
meet requirements of grazing livestock (270) . Furthermore,
parenteral administration of copper glycenate or copper
calcium-ethylenediaminetetraacetic acid (CuCaedetate) in
doses of 120-140 in cattle were shown to be effective
preventive measures against copper deficiency if given at
intervals of 3-6 months (292) . However, another study (290)
reported that a single dose of 100 mg CuCaedetate may be
adequate in cattle.
In humans, a daily copper intake of 80 ug/Kg has
been recommended for infants (30,62). Based on balance
studies, safe and adequate copper intakes were determined at
2-3 mg/day (30,62) or 1.3 mg/day (292,297) in adults and
children. However, 1 . 3 mg copper has been estimated as daily
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requirement in preadolescent girls (298)
.
Food sources as oysters, organ meals, green
vegetables and many varieties of fish are considered copper
rich meals (100 ug/100 Kg), while cheese, bread, mutton, beef
and milk are poor sources (49,53). Soft water could provide
copper in amounts varying from 0.4 mg/day (299) to 1.4
mg/day (270) and may cause chronic copper poisoning in
infants (300)
.
The bioavailability of copper has been shown to be
little affected by phytate or fiber (52,53). Conversely,
another study (297) indicted that bioavailability of copper
is affected by fiber phytate, starch and copper deficiency.
Other nutrient components such as ascorbic acid (2 36) , zinc
(301,302), silver, mercury and cadmium (303) and iron (304)
could induce antagonistic influence at the absorptive and
metabolic levels.
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CHEMISTRY
Copper has an atomic number of 29 and
molecular weight 63.54. It occupies a position between
nickel and zinc in the subgroup IB of the periodic table.
Copper comprises about 0.007% of the earth's crust. Copper
exists as sulphide ores exemplified by chalcocite (Cu^S)
,
covellite (CuS)
, chalcopyrite (CuFeS
2 )
and chalcanthite
(CuSo
4
.5H
2
o)
.
Copper valencies vary between 1+ and 2+. Despite
the fact that copper does not replace hydrogen from
solutions, it is readily soluble in oxidizing acids such as
nitric acid, sulfuric acid and ferric sulfate. Copper is
soluble in ammonia and ammonium salts in presence of air and
in sodium and potassium cyanide. Copper is incorporated in
alloys such as cupronickels, aluminium bronze, silicone
bronze and manganese bronze. In manufacture, copper is
utilized in copper sheet and strip, generators, light bulbs,
telephones and light and power lines. (56)
.
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BIOCHEMISTRY
Like many other trace elements, copper pursue
a number of biological functions represented by proteins and
enzymes. Copper proteins have been encountered in molds
(galactose oxidase)
, bacteria (azurin)
,
plants (laccase) and
animals (ceruloplasmin) with molecular weight ranging from
10,790 to 7 million (92). Copper proteins are conviently
classified into two main divisions depending on their color;
blue and non-blue. Many plant oxidases belong to blue class,
whereas those of animal origin belong to non-blue class
(92) . Copper is able to reduce oxygen to water or carbon
peroxide (306) .
Unlike other enzymes, cuproenzymes possess high
potentiality for oxygen depending on the number of
incorporated copper atoms (307) . All cuproenzymes containing
4 atoms, except cytochrome oxidase, are capable of reducing
oxygen to wate, while those containing 1 to 2 atoms reduce
oxygen to hydrogen peroxide (307) . Hydroxylase, a
cuproenzyme, is known to incorporate one molecular oxygen
into its substrate with subsequent hydroxylation (308,309).
Cytochrome oxidase is involved in energy supply for muscle
contraction (309,310) in aerobic organisms mainly in the
heart (92), flight muscles of birds and insects (310), liver
mitochondria (311) and gray matter of brain (312)
.
Ceruloplasmin (ferroxidase) occurs in mammalian serum (313)
with molecular weight of 150,000 and eight copper atoms/
78
mole protein (314,315). The number of copper atoms bound to
each molecule is a matter of conjecture (314,316). As an ion
transport enzyme, ceruloplasmin activity has been studied in
vitro (317,318) and vivo (319). It has been shown that
copper ceruloplasmin plays a vital role in copper (320,321)
and iron transport (768) and in regulation of biogenic
amines (322,323). Superoxide dimutase is known to protect
cells from oxygen damage (92) . Only relatively few amine
oxidases which are involved in oxidative deamination (324) .
Two types of copper-binding proteins has been
reviewed; metallothionein and (Cu- , Zn) -thionein.
Metalothionein of horse liver and kidney contains 0.14
copper atoms/ mole (325) . Brenner and Young (326) speculated
that some zinc atoms of (Cu-, Zn) -thionein of rat liver could
be substituted by copper atoms. Subsequent studies isolated
another copper-binding protein having the same amino acid
composition, except cysteine, from bovine (327) and human
(328) fetal liver. Copper-chalatin (329) , is a copper-
binding protein which was isolated from yeast and liver
cytosol of rat (330) , rabbit and chicken (329) . A copper-
binding protein with similar amino acid composition, but
lower cysteine content, and molecular weight of 7,000, 9,000
or 12,000 has been isolated from liver of human (331), rat
(332) and pig (333) and rat intestine (92). Thus, copper
loading will induce synthesis of copper-substituted
metallothionein, (Cu-,Zn)
-thionein (326), or specific copper-
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binding proteins with lower cystein content (334) . With
exception of albocuprein I (330) , copper has been shown to
exist in cuprous form in proteins (330,331). Copper-binding
proteins have been shown to be involved in detoxification
(333) and bioenergetics (329), but their precise role
remains to be elucidated.
80
METABOLISM
ABSORPTION:
Copper bioavailability is substantially
influenced by the nutritional status of the individual, its
chemical form and interaction with other dietary factors
(270)
.
Although absorption occurs via the entire alimentary
tract, larger proportions take place in human stomach (335)
and large intestine of sheep (270) . There is sufficient
evidence that copper absorption is increased in copper-
deficient subjects than with copper adequate state
(336,337). However, copper absorption increases in saturated
state (338) . The potential role of metallothionein as
a transport and interaction site for copper and zinc has
been reviewed by Cousins (339) . Due to the hypothesis that
metallothionein has strong affinity to copper than zinc,
copper absorption is greatly influenced by metallothionein
(270). Other unknown factors in bile, pancreatic juice,
intestinal and gastric secretions were known to be limiting
factors for copper absorption (231,340). Copper absorption
increases in malgenancies and decreases with estradiol
administration, despite increased ceruloplasmin activity
(341)
.
Moreover, copper absorption has been shown to vary
considerably depending on moisture content (342,343) and
presence of organic ligands (334) in the feed. Sulphate and
sulphite also reduce copper absorption by forming insoluble
complexes (270)
.
Phytate can reduce assimilation of copper
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(345) . Dietary protein are known to enhance copper
biological availability (346,347).
Underwood (348) illuminated the essentiality of
exogenous factors, especially other mineral, in influencing
of copper status of an individual. The mutual antagonistic
effects of copper and zinc have been demonstrated in many
studies (268,349,350). Metal ions such as zinc, cadmium,
silver, mercury, induce antagonistic effects to copper
absorption (351,352), possibly by competing at the copper-
binding protein in intestinal wall (353) . Pharmacological
doses of zinc was shown to induce copper deficiency in
humans
,
which was ameliorated on copper supplementation
(354)
.
Excessive dietary zinc could induce metallotheinin
synthesis which preferentially render copper unavailable to
biological systems (269) . An evidence of copper-selenium
interaction represented by reduction of peroxidase activity
has been evident, however the mechanism is not known (355) .
Excessive dietary calcium was reported to potentiate copper
toxicity in swine (278) and to reduce copper absorption in
mice (278)
.
Interaction of copper with molybdenum or
ascorbic acid plays a vital role in copper bioavailability
(337,356). The negative effect of ascorbic acid on copper
absorption was demonstrated in chicks, rats, and humans
(337,357,358), and that the mechanism may be mediated by
reduction of cuprous ions or formation of stable complex.
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INTERMEDIARY METABOLISM:
Despite the majority of absorbed copper is
bound to ceruloplasmin, copper may also be transported
loosely bound to albumin or certain amino acids (270) . The
latter mean of transportation renders copper readily
available for liver and other tissues (56) . Dietary copper
is a powerful determinant of cholesterolemia (359). Liver
represents the main site of copper metabolism (360), and
that uptake by hepatocytes is saturable and temperature
dependent (361,362). Cyanide and n-ethylmaleimide (362)
induced significant inhibition of copper uptake by
hepatocytes. However, Saltman and collaborates (361) did not
demonstrate significant change by other metal ions. Amino
acids, on the other hand, have been shown to enhance copper
by hepatocytes probably through complexation with copper
(363).
Inside liver parenchymal cells, copper accumulates
in mitochondria, microsomes, nuclei and soluble fraction in
proportions varying with age (364,365), strain (136,366) and
copper status of animal (364,367). It has been demonstrated
that more than half of incorporated copper is confined to
supernatant fractions, possibly metallothionein, SOD and
other copper enzymes (368,369). Phenobarbital administration
has been found to increase microsomal copper content of rats
receiving normal diet (56)
.
Copper enzymes has been widely reviewed (370)
.
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Ceruloplasmin and erythrocuprein are the vehicles that
transport copper from liver to target organs (56) .
Ceruloplasmin enzyme is thought to be involved in defense
mechanism against neoplasm, infection, inflammation and
stress (339,371). Furthermore, ceruloplasmin displays a
variety of functions including oxidation of biogenic amines,
iron transportation and destruction of super oxide radicals
(372) . Iron mobilization involves conversion of Fe to Fe3+
with subsequent reduction of ceruloplasmin-bound Cu2+ to
Cu (373)
.
Serum iron concentrations, ceruloplasmin levels
and hemoglobin are directly correlated in the biological
system (219,374). Anemia could be alleviated with copper
(4) . Iron metabolism is impaired with severe depression of
ceruloplasmin activity, although depressed ceruloplasmin
levels does not always reflect anemia (227,372). Lysyl
oxidase, a copper metalloenzyme necessary for cross-linking
elastin and collagen fibers which is necessary for tissue
maturation and bone formation (375,376). Recently, lysyl
oxidase has been hypothesized to cause sudden infant death
syndrome (SIDS) by affecting lung tissues (377) . Some copper
metalloenzymes may be involved in immunocompetence and
inflammatory responses (378) . The physiological roles of
some copper-dependent enzymes including; albucuprien I and
II, neurocuprein, pink copper proteins and diamine oxidase
are not fully understood (379,380,381,382).
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EXCRETION :
Most of unabsorbed copper is excreted in
feces, while most of the absorbed portion is actively
excreted through the biliary system in all species (56,270).
Biliary excretion of copper represent the major excretory
route in humans (383,384,385), dogs and pigs (386,387) and
mice and poultry (388) . However, biliary excretion of copper
revealed no significant increase in Wilson's disease despite
considerable accumulation of element in the liver (335)
.
Literature had shown disparity regarding copper
concentration in urine (152,385). However, copper in
concentrations of 3.8-6.6 ug/L (389,390) or a daily copper
excretion of 5-50 ug in adult urine was considered normal
(270) . Increased serum an biliary levels and decreased
urinary excretion of copper have been observed in
adrenalectomized and hypophysectomized cats (270) . Increased
urinary losses of copper is induced by increased molybdenum
intakes (391) . Moreover, urinary excretion of copper
increased in patients with liver cirrhosis and biliary
obstruction (270) . Minor excretory routes of copper were
sweat (392) and normal menstrual flow (393). Larger
guantities (0.4 mg/day) of copper, imposing no nutritional
hazard, could be excreted during highest human lactation
(56).
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COPPER DEFICIENCY
Frank copper deficiency, associated with soil and
crop copper, has been reported in cattle (394). Blood
disorders including anemia (395) , leucopenia (396) and
neutropenia (397) have been shown in copper deficiency.
Since ceruloplasmin is essential in oxidation and
incorporation of iron into transferrin (398) , its deficiency
will impede the release of iron from liver and
reticuloendothelial system (399) with subsequent development
of anemia. Such evidences were not noticed by other
investigators (400,401,402), but increased breakdown of heme
was postulated as a result of increased accumulation of iron
in the liver (403) . Moreover, it has been reported that the
life-span of red cells is shortened in copper-deficient pigs
(404).
Copper deficiency is associated with skeletal
abnormalities in rabbits (405), chicks (406), pigs (397),
sheep (407,408) and children (409). Skeletal abnormalities
was not observed in lambs fed copper-deficient diets, but
rather encountered in lambs borne to copper-deficient ewes
(410)
.
Such skeletal abnormalities and reduced strengths of
collagen and elastin were attributed to reduced amine
oxidase or lysyl oxidase activities (376,411).
Neonatal ataxia of lambs is a nervous disorder,
demyelinating encephalopathy, associated with copper status
of animal, and has also been termed "swayback" (412). The
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conditions is caused by copper deficiency in lambs, ewes or
pastures (413) , and could be ameliorated on copper
supplementation (413). Other studies, however, did not
demonstrate such relationship (412,414). Swayback has been
developed experimentally in molybdenum- (415) and lead-
supplemented (412) lambs. Neonatal ataxia has also been
reported in goats (416)
,
guinea pigs (282)
,
young pigs (417)
and rats (418) .
Intermittent scouring has been reported in copper
deficiency in cattle (419,420). "Peat scours" was ascribed
to high dietary molybdenum in New Zealand cattle (373)
.
"Falling disease", a cardiac abnormality described in cattle
grazed on copper-deficient pasture (416) , but was not
encountered in horses and sheep grazed in the same area
(421) . Acute heart failure and hypertrophy of heart and
brain were shown in pigs (422) and rats (423) as a result of
copper deficiency. Mortalities related to abnormality of
elastic tissues of aorta were reported in copper-deficient
guinea pigs (414,422), chicks (424) and pigs (425). Such
aortic lesions may be attributed to defective activity in
lysyl oxidase (426,427) or amino oxidase (428), copper-
dependent enzymes. Experimental copper deficiency has led to
dissecting aneurysm in chicks (418) . Decreased in ATP levels
(429), systemic blood pressure (430,431,432) and
norepinephrine levels (433) were reported in copper
deficiency.
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There is apparent discrepancies regarding the
effect of copper deficiency on the ratio of saturated and
unsaturated fatty acids (336,434). In rats, copper
deficiency has led to accumulation of n-3 and n-6 longer-
chain polyunsaturated fatty acids in triglycerides of
various tissues (435) . Increased lipid peroxidation due to
inhibition of SOD, catalase and glutathione peroxidase in
the liver (436) and erythrocyte membrane (437) has been
encountered in copper deficiency (355,436). It has been
hypothesized that hypercholesterolemia of copper-deficient
rats is caused by suppression of cholesterol degradation
process (438)
.
Fetal death and infertility in sheep, guinea pig
and rat (439,440), reduced hatchability in hens (441) and
delayed or suppressed estrus in animals (420) are yet other
consequences of copper deficiency. Recently, congenital
copper deficiency has been hypothesized to cause sudden
infant death syndrome (377) .
Several studies have demonstrated a relationship
between copper deficiency and impairment of glucose
metabolism (442,443,444). There is hypothetical evidence
that copper plays essential role against inflammation
(445,446). Immunosuppression has been described in rats as a
result of depressed SLC proliferation (447) . Decreased
pigmentation of hair, achromotrichia, has been noticed in
several animal species, but not in pigs (270) . Impaired
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keratinization is another sequelae of copper deficiency
(408,426)
.
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COPPER TOXICITY
Studies on copper toxicity has begun over a
century ago. In 1874, Harnack (448) emphasized subcutaneous
lethal doses of copper in dogs, rabbits and frogs. Gallipe
(449) , on the other hand, noted copper poisoning in farm
animals. Early, the accumulation of copper in liver and
other tissues of copper-poisoned animals has been reviewed
(270). Chronic copper toxicity syndrome in man, Wilson's
disease, has been shown to develop following accumulation of
copper in renal tubules, brain and cornea as a result of
increased copper-binding proteins (450,451).
Of all ruminants, sheep is relatively the most
susceptible species to copper toxicosis (452) . Copper
toxicity in sheep has been associated with copper-
supplemented diets (453,454), dietary mineral supplements
(455), swine feed or waste (456,457), overdosage in swayback
disease (458) or molluscicide-sprayed pastures (459) . Diets
deficient in molybdenum (460) , high in heliotrope or clover
(452) may predispose for copper toxicity. Chronic copper
poisoning is characterized by accumulation of copper
principally in cytosol (461) of liver (462,463) of sheep,
and clinically manifested by hemolytic crisis, drop in
hematocrit level and hemoglobinemia (464) . Recently, it has
been suggested that copper toxicity in sheep could be
alleviated via complexation by ciliate protozoa (465)
.
Enzymes such as serum glutamic oxaloacetic
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transaminase (466,467), liver-specific arginase (468),
glutamate dehydrogenase and sorbitol dehydrogenase (466)
were found to be significantly elevated in copper poisoning.
Copper was shown to be sequestered in hepatic lysosomes
(469) whose density and volume increased significantly 48
hours before onset of hemolytic crises (470) . Following
hemolytic crisis, plasma methemoglobin (471) and blood urea
levels (466) may be elevated. Liver necrosis of copper
toxicity is thought be associated with release of lysosomal
enzymes (470) . Renal tubular degeneration and necrosis (472)
developed when renal copper accumulation reached 240 ug/g
wet weight (466)
.
Goats are more tolerant to copper toxicity than
sheep (473). However, acute copper toxicity has been
encountered in goats with lesions of diarrhea, jaundice,
hepatic necrosis and hemosiderosis (474) . Copper
concentrations rose from 19 to over 2000 ppm in liver, 7 to
over 300 ppm in kidney, 3 to over 140 ppm in spleen and 9 to
over 30 ppm in heart (475)
.
In cattle, moderate dietary copper concentrations
was not injurious (476) , and increased weight gain of calves
(477)
.
The toxic dose in cattle has been estimated 3 to 12
times the dose required to correct copper deficiency (478)
.
Acute poisoning is characterized by an abrupt increase of
hepatic copper to over 2000 ug/g dry weight with subsequent
centrilobular necrosis (479) . In chronic copper poisoning
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the onset was insidious and characterized by hemoglobinuria
and hemoglobinemia and icterus (480,481).
Pigs showed increased growth rate at 250 ug/g
added dietary copper only when suitable amounts of zinc and
iron (482) or proteins (252) were added. Two fold elevation
of copper was encountered in liver, kidney, bile and
gastrointestinal tract of 250 pp copper-supplemented boars
(483) . High levels of hepatic copper is the only overt sign
of copper toxicity in swine (484) . Females are more
susceptible than males (278) , and that dietary copper level
of 700 ppm was considered fatal to pigs (485)
.
Rats appear to be tolerant to copper toxicity. A
dose of 250 ug/g developed no sign of toxicity (486) , but
feed conversion increased in males and decreased in females
(487). Acute toxicity with larger doses had resulted in
increased alkaline phosphatase (488) and copper in liver
particulates, but not cytosol (489). In chronic toxicity,
copper accumulated in liver in proportions directly
correlated to copper dosage (490) particularly in
subcellular particles (491,492), despite increased lysosomal
levels (493) . Organs affected other than liver were kidney
(34) and heart (494). Biphasic serum copper elevation was
observed in rats fed excess copper for 15 weeks (495) .
Copper toxicity in rats could be potentiated in rats by
feeding heliotrope alkaloids (496) , sodium azide (497)
,
carbon tetrachloride or alpha-naphthylisothiocyanate (498)
.
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Oysters (499), penicillamine (500) and ciliate protozoa
(465) have been found to be effective in copper-laden
animals.
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IRON
ORIGIN:
Iron is necessary to biological mechanisms
and therefore exists in all living matter. It occurs in
ferrous form in igneous and metamorphic rocks and in ferric
state in sedimentary rocks (501) . Iron salts are generally
confined to poorly drained acid soils (502) . Sedimentary
iron has been extensively reviewed (503,504), predominantly
as ferric oxyhydroxides. Carbonacious deep sea sediments
(505) and oceanic oxide-rich sediment (506) estimated to
contain up to 11% and 15% iron, respectively. The most
important iron ores are sedimentary in nature and most iron
stones are distributed around the Atlantic and Indian oceans
(507).
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ESSENTIALITY AND REQUIREMENTS:
Over a century ago iron was discovered to be a
constituent of blood (348) . Early studies regarding the
essentiality and involvement of iron in oxidative mechanisms
has been reviewed (1) . Iron-containing flavoprotein were
subsequently discovered (508,509), and it became evident
that lack of dietary iron inhibit iron-dependent enzymatic
processes (510,511).
Swine are devoid to iron balance due to their
rapid growth and low iron stores at birth (287) . Piglets
must receive 21 mg/Kg (512) to attain adequate iron , while
125 mg is necessary for full growth (513) . The recommended
dietary allowance, however, for growing pig has been
estimated at 80 mg iron/Kg dry matter (514).
Iron requirements of chicks has been suggested at
50 ug/g iron (501) and as high as 75-80 u/g diet in another
study (511) . However, it has been recommended that 80 ug/g
is necessary for the first 8 weeks of age and 4 ug/g for
the end of 18 weeks in poultry (515) . Another study (511)
showed that chicks require 75-80 mg iron/Kg when fed a
soybean-protein or a casein-gelatin based diet.
Matrone et al (516) suggested 30-60 mg iron/day
for normal hemoglobin and growth in calves fed milk diets
from birth to 4 weeks of age, but Blaxtar et al (517)
proposed 100 mg iron/day. Estimate amounts to 40 ug iron/g
diet was reported adequate for calves 17 days to 11 weeks of
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age when fed a fat-supplemented skim milk diet (518) .
Milking cows require 50-60 mg/day, while pregnant cows need
60-80 mg iron/day (519)
.
The minimal requirements of growing lambs was
estimated at 25 ppm but not more than 40 ppm (520) . Iron
requirements for mature sheep are limited, but 10-15 mg/day
was estimated when animal feed averages 10-15 ppm iron
(519).
In humans, iron requirements for growth through
infancy, childhood and adolescence amount to 30 mg iron/Kg
increase in body weight (501) . The recommended daily
allowances have been estimated at 10-15 in infants and
children ages 5-10, 10-11 mg in males and females ages 11 to
15 and 18 mg for lactating or pregnant women (62)
.
The richest sources of iron are meat meals and
fish meals (400-600 ug/g) , blood (3000 ug/g) , egg white,
cocoa, cane molasses, parsley and shell fish (515) . Foods
that are poor in iron are milk, milk products, white four,
white sugar, bread and most fruits (515) . Intermediate
sources are muscle meat, poultry, nuts and green vegetables
(515).
There are some studies concerning animal feed
analysis (521,522,523). Animal feeds were estimated to
contain 100-250 mg /Kg grasses, 200-300 mg/Kg legumes, 30-60
mg/Kg cereal grains and 100-200 mg/Kg oil seed meals (523).
Iron content of some inorganic materials fed to livestock
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amounts to more than 500 ug/Kg; these include ground
limestone, rock phosphate, ground oyster shells and
dicalcium phosphate (523)
.
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CHEMISTRY
Iron has an atomic number of 2 6 and atomic
weight of 55.847. It is classified in Group VIIIB of the
periodic table. Iron is tetramorphous and comprises
approximately 5% of the earth's crust. Iron occurs in delta,
gamma, beta and alpha forms at temperatures above 14 00°C,
below 1400°C, 895°C and 766°C respectively. Iron ores are
hematite (Fe^Oj)
,
brown ore, magnetite (Fe^O.) and siderite.
Iron valency could be 2+ or 3+ in oxidation states, 4+ in
2 ? -perfferite (Fe0
3 )
and 6+ in ferrate (FeO^ ) . Nonoxidizing
acids convert iron to ferrous ion with subsequent reduction
of hydrogen ion to hydrogen gas. Oxidizing agents induce
formation of ferrous ion in presence of excess metal and
ferric ion in presence of excess oxidizing agent. Rusted
iron is principally ferric oxide (56)
.
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BIOCHEMISTRY
Total body iron content is influenced by age,
nutritional status and species of the animal (515) . Human
body contains about 60-70 ug/g (524) , while that of rat
contains about 50 ug/g of the whole body (525) . Iron is
predominantly confined to hemoglobin and it was estimated at
57% in dogs (515) and 60-70% in humans (526) . Iron content
has been shown to be affected by sex in rats (527) , mice and
birds (528) but not in humans (524).
Blood iron is mainly represented by hemoglobin and
transferrin in a ratio of 1000:1 (515). and by ferritin in
human blood (529) , serum (530) and leukocytes (529) . Serum
transferrin or siderophilin is an iron-binding protein (531)
in all vertebrate species (532) . Transferrin is a
glycoprotein with two iron-binding sites (533) and molecular
weight of 76.000 in humans (515). Serum transferrin has been
shown to play a role in iron transportation (534) and in
body defense mechanism against infection (535) . Serum
ferritin levels has been correlated to total body iron
stores (536,537), but not when concentrations are low (538).
It was reported that ferritin is a useful diagnostic tool of
storage iron (534) . Walters and associates (537) suggested
that 1 ng/ml of serum corresponds to about 8 mg of storage
iron. Serum ferritin has been found to increase in liver
diseases (515) and in leukemia (539)
.
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Hemopexin (540) and hepatoglobin (541,542) are
glycoproteins secreted by liver. Following intravascular
hemolysis, hemopexin binds heme, while hepatoglobin binds
hemoglobin to liver for catalysis and iron conservation, a
process that is receptor-mediated (543,544,545).
Iron is stored in two main forms; ferritin and
hemosiderin, occurring in all tissues with highest
concentrations in liver, spleen and bone marrow (546) . In
its crystalline form, ferritin contains up to 20% iron,
while hemosiderin contains up to 35% iron in a form of
ferric hydroxide (515) . It has been proposed that
hemosiderin provides a useful diagnostic measure for body
iron stores (547) and iron deficiency anemia (548) . The
amounts and proportions of ferritin and hemosiderin are
affected by a number of factors (549,550). Ferritin-
hemosiderin ratio was little affected in with chronic or
acute hemolytic anemia (515) , iron-deficient chicks (551)
,
but not with iron supplementation (552) . Iron is
predominantly deposited as hemosiderin in patient with
hemochromatosis and transfusional siderosis (549),
nutritional siderosis in cattle (553), copper and cobalt
deficiency in sheep (554) or when iron levels in liver and
spleen are beyond 2000 ug/g (552)
.
Iron occurs as ferritin of lactoferrin in milk
(555) as well as saliva and sweat (556) . Lactoferrin and
ferritin are similar in their iron-binding sites, however
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they differ in their immunological specificity (557) , amino
acid and peptide composition (556) and electrophoretic
motility (555)
.
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METABOLISM
ABSORPTION:
Intestinal mucosa tend to regulate iron
absorption (558) with most absorption encountered at
duodenum (501)
.
Due to restricted pathways of iron excretion
(559), about 5-10% of iron is absorbed depending of the food
source and 10-20% in deficient subjects (56). In general,
iron in ferrous form is highly absorbed compared to ferric
form (560)
.
Iron from heme sources is directly absorbed into
mucosal cells, while iron of nonheme and iron protein
compounds needs to be reduced to ferrous form for effective
absorption (561) . Normal gastric juice is capable to
accomplish these transformation (562,563). The
bioavailability of iron from soybean is greater than from
corn or wheat in humans (564,565).
Regulation of iron absorption is not mediated via
a hormonal factor in plasma (566) , but Bhargavra and Gabbe
(567) suggested that iron absorption is influenced by
erythropoietic activity of the erythron. Mucosal transferrin
has been suggested to be involved in transmucosal transport
of iron (428,568), and that its concentration was found to
be directly proportional to iron uptake (428). Simpson and
collaborates (569) reported ferric iron uptake by brush
border membrane viscles. Another study (570) demonstrated
that apomucosal transferrin may be involved in
transportation of iron between cells and brush border.
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Unlike inorganic iron, heme iron is absorbed directly by
intestinal epithelial cells and subsequently released in
nonheme form (561,571). Gastroferrin, a glycoprotein of
gastric juice, has been postulated to regulate iron
absorption (562), and its deficiency has been correlated to
the development hemochromatosis (515) and iron deficiency
anemia (572)
.
Dietary interactions of iron with cobalt, zinc,
copper, cadmium and manganese contribute considerably to
interference with iron absorption possibly by competing at
the absorption site (515) . A supplement of 10 or 100 fold of
cobalt could reduce or inhibit iron absorption (573)
indication shared absorptive pathway. This has been
confirmed when iron and cobalt absorption increased in iron-
deficient rats (574) and iron deficiency in humans (575)
.
High dietary phosphorus decreased iron absorption (576) and
increased fecal excretion of iron in presence of low or high
intakes of calcium (577)
.
Histidine, lysine and cysteine could influence
iron absorption (578,579). Several studies showed that
ascorbic acid increases iron absorption (580,581,582), but
no effect was revealed on hemoglobin, iron absorption (561)
or iron utilization from wheat sources in rats (583) .
Phytate significantly depressed iron absorption when added
to human diets (584,585). However, sodium phytate did not
affect iron utilization when added to rat diets (586,587),
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nor did it affect iron utilization from wheat bran in rats
(583,588). Iron absorption is enhanced in the presence of
organic acids such as citric, lactic, malic, pyruvic,
succinic and tartaric (589,590). Meat content "meat factor",
fish, poultry or MFP enhanced iron absorption (590,591)
compared to vegetable foods (565)
,
possibly by the formation
of luminal iron transport carrier (592) through amino acid
cysteine (593,594). Carbohydrates such as starch, lactose,
glucose and sucrose (595) , ferric fructose (596) , fructose
(597) and sorbitol (598) enhanced iron absorption and
retention. Bicarbonate or phosphate therapy produced no
significant impact on iron absorption, whereas
desferoxamine, by contrast, reduced iron absorption
significantly (599,600), and it is therefore necessary to
counteract iron overdosage (524,601). Of beverages, tea
(602) and coffee (603) showed inhibitory effect upon iron
absorption.
The potential uptake of iron is considerably
modified by disease state (515) . Iron absorption increased
in hemolytic anemia, plastic anemia, pernicious anemia
,
pyridoxin deficiency and hemochromatosis (604) and in
increased erythropoiesis (605) , but decreased in
transfuginal polythcythemia (606) .
INTERMEDIARY METABOLISM:
Following absorption, iron is normally bound to
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serum transferrin or siderophilin (531) almost in all
vertebrate species (532) . Diurnal fluctuations in serum iron
has been observed in man (607), pigs (608) and dogs (609).
Species variation in serum iron and total iron binding
capacity (TIBC) is small, however average values encountered
were high in sheep, pigs and cattle (608,610,611) than
humans.
Incorporation of plasma iron into liver, spleen
and bone marrow ferritin is mediated via ATP and ascorbic
acid (612,613). It has been shown that molybdenum and
xanthine oxidase facilitate release of iron from hepatic
ferritin to plasma (398,613), but Osaki and Sirirech (614)
did not detect such release. Ceruloplasmin (ferroxidase I)
has been shown to participate considerably in mobilization
of iron from its stores (219,615).
Among metabolic cycles of iron hemoglobin cycle is
the largest, and that 70% of plasma iron turnover is confined
to bone marrow (91) . The process of hemoglobin synthesis
involves transfer of iron via transferrin (616) . Ferric iron
transported to bone marrow is reduced and released into
ferrous form before being incorporated into protoporphyrins
during biosynthesis of heme (617,618). Transferrin-iron
complex is taken up by immature reticulocytes with
subsequent release of transferrin to plasma (619,620). About
80% of iron is transformed to hemoglobin within mitochondria
of erythroid cell (621). The adequacy of iron supplement
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versus erythroid need may be monitored by increased cell
protoporphyrin (390) . Iron of senescent or defective red
cells in reticuloendothelial cell is catabolized and either
taken up by transferrin (609), ceruloplasmin (622) or stored
as ferritin (623) .
Iron storage forms are ferritin, hemosiderin with
highest concentration in liver, spleen and bone marrow
(515) . Ferritin is a water soluble compound containing 20%
iron, whereas hemosiderin is water insoluble and contains
35% iron (624,625). The hemosiderin: ferritin ratio was found
to be increased in favor of ferritin when iron
concentrations were high (1000-4000 ug/g) in liver and
spleen of rats and rabbits (626) and humans (549) . The
reverse was true in poultry (551) and at low iron storage
concentrations (549) . Iron is stored as nonheme iron at 100
ug/g in bone marrow of normal humans (627) and in relatively
small amounts in the muscles (627,628). In healthy subjects,
there was evidence of direct correlation between serum
ferritin and iron stores in the body (536,537), but this
relationship was not longer maintained in disease states
(629) or at low concentrations (538) . Hepatic uptake and
storage of iron is potentiated when erythron uptake
decreases (630)
.
EXCRETION:
Early studies have suggested limited excretion of
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iron from the body (559) even in the occurrence of iron
overload (631) . Using chemical balance studies (632) and
radioiron techniques (633,634), the amount of excreted iron
was estimated at 0.2 and 0.3-0.5 mg/day in normal human
adult respectively. Iron was shown to be excreted in bile at
1 mg/day mostly from hemoglobin breakdown, and that it may
be absorbed by 40% before reaching feces (635) . Green and
co-workers (634) estimated iron losses in adult male. It has
been demonstrated that iron losses are directly correlated
with iron stores (636) or inversely correlated with
absorption (637) . Urinary iron excretion increased in
presence of chelating agents (deferoxamine) (638) and in
nephrotic syndrome (639) .
Iron losses through integument amount to 0.5
mg/day in healthy adults (640) and as high as 6.5 mg/day in
some instances (641) , which was claimed to contribute to the
incidence of iron deficiency in the tropics (641) . A net
loss of 0.8-1.0 mg iron/day was estimated in urine, feces,
and sweat in women and men of average size (642). Iron
losses amount to 0.4 mg/day during lactation, but menstrual
losses were considerably variable among women (643,644).
Menstrual losses have been estimated at 4-2 6 mg/period in
young women (645) , 2-59 mg/day in adolescent girls (646) and
27-37 mg was regarded as upper limit for normal loss (644).
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IRON DEFICIENCY
Iron deficiency syndrome is expressed by three
stages; depletion of iron stores, latent iron deficiency and
overt iron deficiency anemia (647,501). The clinical
manifestations of iron deficiency are associated with
listlessness, fatigue, sore tongue, angular stomatitis and
dysphagia in human adults and by anorexia, depressed growth
and immunosuppression in children and young growing animals
(648,515). Gastric achlorhydria, gastritis, atrophy (649)
and reduced plasma proteins (650) were observed in iron-
deficient infants and children. Some studies indicated that
loss in weight gain is a late consequence of iron deficiency
in rats (651,652) but not in children (653,654). One study
demonstrated that anemia is associated with 78% of anemic
pregnant women and that there is a correlation between
maternal and newborn hematopoiesis (655)
.
Iron deficiency anemia was encountered in pigs fed
copper as a growth factor (656,657) and in baby pigs
exclusively confined to sow's milk (515). Iron deficiency
anemia has been reported to occur in calves and lambs only
under heavy helminth infestation (658) or when reared under
milk-based diets (546,659). A diversity of methodology has
been utilized to monitor iron deficiency with certainty
(660,661,662). However, values of transferrin iron
saturations of less than 15% are used as criterion of iron
deficiency (647)
.
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Dietary iron deficiency has been had resulted in
lipid abnormalities and increased triglycerides in rats
(663,664) and chicks (665). Hyperlipidemia was reversibly
correlated to iron supplementation in rat (666) . One study
(667) suggested mild impairment in essential fatty acid
metabolism in moderately (12 mg/Kg) iron-deficient rats.
A significant drop in myoglobin content has been
reported in iron-deficient piglets and puppies (668) , chicks
(551) and rats (551,651). Furthermore
,
young animals (668)
and skeletal muscles (551,669) are most vulnerable to
myoglobin loss in iron deficiency. However, chronic iron
deficiency anemia of moderate or severe degree did not
induce significant alterations in enzyme activity, capillary
density or myoglobin content of human skeletal muscles
(342).
Biochemical measurements showed that cytochrome
oxidase is reduced in intestinal mucosa in iron-deficient
subjects (670,671), and in intestinal mucosa and skeletal
muscles of iron-deficient rats (672) . Decreased cytochrome C
activity (651) and catalase activity (673) were encountered
in iron-deficient rats, piglets and calves. Aconitase
activity depressed in iron-deficient patients (51) , and
normal or decreased in tissues of iron deficient rats (510)
.
Although the relationship between human iron
status and susceptibility to infection is controversial
(674), impaired cell-mediated immune response and
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bactericidal activity in children (675) and impairment of
antibody formation in rats (676) were ascribed to iron
deficiency. Enhanced susceptibility to E.Coli infection was
observed in iron-deficient piglets (677)
One study (678) speculated that iron deficiency
induces behavioral abnormality in children and adults,
however the mechanism and extent in which iron deficiency is
responsible remains to be established. In rats, spontaneous
basal activity diminished in presence of iron deficiency,
but it was independent of severity of anemia and corrected
upon iron therapy (679) . Reduction in scholastic achievement
reported in association with iron deficiency (680) , but not
in another study (681) . Pica or alotteriophagia was observed
in iron-deficient patients (682,683), but direct
relationship was difficult to achieve. However, deficiency
of monoamine oxidase in brain of iron-deficient rats (684)
and humans (685,686) raised the likelihood of that this
enzyme may be associated with behavioral disorders of iron
deficiency.
The potentiality of manganese absorption increased
in iron deficiency (574,464) and decreased in individuals
with adequate iron stores (464) . The absorption of cobalt
(574,575) and lead (687.688) have been shown to be increased
in iron-deficient rats. Cadmium absorption increased by 4 to
6-fold in iron deficient rats (689) . There was no
significant change regarding absorption of cesium,
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magnesium, calcium and copper in iron-deficient rats (574)
.
Iron deficiency has been shown to depress cell
proliferation of cheek pouch epithelium of hamster (690)
.
Several studies have demonstrated injury to mitochondria in
various tissues of iron-deficient animals and humans
(691,692). A significant drop in serum folic acid has been
observed in iron-deficient subjects (693) , which may be a
sequelae to decreased red cells life-span (694,695),
ineffective erythropoiesis (696) or lactation (697)
superimposed in iron deficiency.
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IRON TOXICITY
Although iron intake levels of 50 mg/day (698) or
25-75 mg/day (515) is regarded safe for humans, accidental
toxicity have been reported in children (699,700) and may be
fatal (701,702). Fatalities in adults were associated with
suicidal intent (703,704). The adult lethal dose was
estimated at 200-250 mg iron/Kg body weight (702) . Iron
toxicity in animals requires much higher levels of iron in
presence of high in takes of cobalt, zinc, manganese, or
copper than when such intakes are low or normal (515) .
The clinical stages of acute iron poisoning have
been described (705,706) and may show marked leucocytosis,
metabolic acidosis, hyperbilirubinemia and deranged blood
coagulation (682,707). The onset or shock is an indication
of serious prognosis (706) and the case mortality rate was
11-17% (706,708). Foals in the immediate postnatal life are
highly susceptible to acute iron toxicity from low levels
(16 mg/Kg body weight) probably potentiated by vitamin E and
selenium deficiency (709)
.
Chronic iron toxicity has been reported in
individuals with idiopathic hemochromatosis (710) or
refractory anemia (711,712,713). Fibrosis (714), carcinomas
(715) and occasionally cholangiomas (716) were the synopsis
of idiopathic hemochromatosis. Idiopathic hemochromatosis is
characterized by iron deposits in parenchymal tissues of
many organs (713,714) especially in liver (714). In
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refractory anemia, repeated blood transfusion could cause
iron deposition predominantly in reticuloendothelial cells
of liver, spleen and bone marrow (710) . Thalassemia major is
a genetic syndrome depicted by increased erythroid activity
with subsequent excessive iron absorption from intestine
(717,718) . Chronic parenchymal iron overload exhibited
specific clinical manifestation including liver dysfunction,
diabetes, cardiac failure, endocrine abnormalities,
arthritis, and abnormal skin pigmentation (501).
Chelating agents such as deferroxamine (601) and
ethylenediaminetetraacetic acid (EDTA) (696,719) have been
utilized to cure iron overload. Bicarbonate and phosphate
have been also described to treat iron overload, but Dean et
al (719) showed that this was ineffective in reducing iron
absorption in pigs. Other attempts of reducing iron toxicity
was accomplished by using sodium dihydrogen phosphate that
renders unabsorbed iron into insoluble complex (699,69).
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INTERACTIONS OF ZINC, COPPER AND IRON
The potentiality of absorption, utilization and
excretion of trace elements including zinc, copper and iron
and subsequently their physiological, pharmacological or
toxicological roles in the body may be appreciably
influenced by the presence of other dietary elements, their
concentrations or chemical composition.
INTERACTION BETWEEN ZINC AND COPPER:
Despite the hypothesis that zinc and copper are
apparently antagonistic in the biological systems, their
doses and relative ratios required to produce such
interactions is controversial (720,721,722,723).
It has been reported 40 years ago that zinc high
dietary zinc (1.0%) induced anemia in rats which could be
alleviated on copper supplementation (724). Van Reen (1953)
demonstrated decreased activity of cytochrome oxidase
(copper-dependent enzyme) in the liver of rats fed 500-700
ug zinc/100 g diet, which was reversed on copper
supplementation (224). Ritchie et al (1963) showed that
copper toxicity in pigs was alleviated by dietary zinc
supplementation (266) . Detrimental responses were also
observed by hill and associates when 100 ppm zinc was added
to the diet of zinc-deficient chicks (268). Subsequent
isotope experiments in rats suggested that zinc interfere
with copper metabolism by decreasing utilization and
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increasing excretion but had little effect on absorption
(725).
High dietary and oral zinc therapy had induced
hypocupremia and increased fecal losses of copper
(352,370,726,727). Some studies have described that excess
oral zinc had resulted in anemia (302,728) and leukopenia
(729,730), that responded to copper supplementation (729),
suggesting zinc-induced hypocupremia. Increased copper
retention in mucosal cells with concomitant decrease in
copper absorption was observed in rats fed high dietary zinc
compared to those with a lower zinc in their diet
(389,731,732). Conversely, radioisotope in vitro studies
revealed significant depression of zinc absorption by high
dietary copper (733). These results were subsequently
confirmed (269) , and that a competition and/or inhibition of
copper or zinc absorption occurred when the concentration of
the other is elevated (269) . This approach was thus
exploited for treatment of Wilson's disease (734) and sickle
cell anemia (728)
.
Investigations regarding serosal transport
mechanisms (735) , the potential role of metallothionein in
zinc (122,126) and copper absorption (339) and its
preferential binding of copper (122,389,736) propose that
this protein may be the site of mutual antagonism. There is
hypothetical evidence that zinc induces metallothionein
synthesis in liver of humans (737) and rats (738) and kidney
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of rats (739) which may render excessive copper nontoxic.
Rats fed diets containing 0.4% or more zinc
revealed significant drop in tissues copper and iron (253),
cytochrome oxidase and catalase (740,741). Both zinc and
copper supplements were associated with decreased deposition
of respective element in liver of rat (721) . Depot
parenteral injection of zinc increased urinary copper
excretion and plasma copper concentration in rats (187)
.
However, Kang et al (255) demonstrated unchanged copper
concentrations in all tissues of rats fed based diets
containing deficient or supplemented levels of zinc. Song
and collaborates (254), in contrast, reported increased
copper concentrations in liver, kidney and spleen in zinc-
supplemented rats. Copper concentrations also increased in
tissues of rats fed zinc-deficient diets (742,743).
While it was evident that increased dietary zinc
acts as a metabolic antagonist in ewe lambs (744), dietary
zinc supplementation enhanced copper deficiency and zinc
toxicity in pregnant ewes (745) . It has been shown that a
genetic factor may be involved in mutual competition between
zinc and copper in sheep (267). Supplementary zinc could
alleviate high plasma aspartate transaminase (ASPT) levels
and liver storage of copper resulted from chronic copper
toxicosis in sheep (746)
.
Although copper supplementation increased weight
gain and feed efficiency in growing pigs (747) , another
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study (748) reported skin lesions similar to those of zinc
deficiency which was alleviated on zinc supplementation
(56).
In young horses high dietary zinc had resulted in
skeletal abnormalities due to hypocuprosis (749) . Mean daily
intake of 12-15 mg zinc/Kg live weight depressed plasma
copper concentrations to levels considered to indicate
copper deficiency in cows and calves (750) . The adverse
effect of zinc supplementation on copper status was
moderated by the presence of phytate in the chow of monkeys
(264).
INTERACTION BETWEEN ZINC AND IRON:
Interaction between zinc and iron is
controversial. It was reported that zinc absorption
decreased following intakes of large quantities of nonheme
iron and a single dose of inorganic zinc (751,752,753), but
was not when zinc was administered in an inorganic form
(63,753) or when zinc and iron were administered with meal
(754). Other investigators (158,755) observed reduced
circulatory zinc levels in pregnant women and infants,
although it was not reported in other studies (756,757,758).
Adverse effects of high iron intakes on zinc absorption was
not observed in infants receiving iron fortified formulas
(759). In contrast, high dietary zinc induced anemia and
decreased tissue iron concentrations in rats and chicks
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(756,760), but such effect was not revealed in humans
(38,63) .
Early isotope studies on iron metabolism in rats
fed high dietary zinc suggested that zinc does not interfere
with iron absorption but interfere with iron utilization
(725)
.
However, the antagonistic effect of high dietary zinc
on iron was thought to be at the absorptive level (761,762)
or metabolic level involving alteration in copper metabolism
(271,760). It has been speculated that zinc affects iron
metabolism by interfering with iron incorporation into or
its release from ferritin or by shortening life-span of RBC
(763). It was reported that empty stomach enhances the
inhibitory effects of excessive iron on zinc, although it
was not observed when supplements were provided with a zinc
ligand or meal (754). Despite the proposal that zinc and
iron are absorbed by different pathways (764), other studies
(93,751) had shown inter-element competition at the
absorptive site and that zinc and iron absorption increased
when the concentration of respective element is deficient
(765).
In a radioisotope study (250) , an intake of
59excessive Fe in one test meal or several weeks did not
alter tissue contents of zinc or apparent absorption of
Zn. Conversely, chronic high dietary 65Zn depressed
hematocrit, reduced of 59Fe absorption and retained less
59Fe in tibias and liver of rats, although no effect was
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noticed with intake of high zinc in one test meal (250) .
Zinc and iron concentrations in liver, kidney and pancreas
of female domestic fowl were significantly elevated when fed
diets containing 6 or 20g added zinc/Kg (766) . Other studies
showed that high dietary zinc induced a marked loss of
hepatic iron (158,253) and decreased amounts and percentage
of ferritin-bound iron in liver of rat (271). However, it
has been suggested that feeding normal, subnormal or toxic
amounts of zinc may also cause a marked decrease of iron in
kidney and liver of rat (255)
.
Feeding zinc-deficient diets had resulted,
although not different from controls, in increased iron
concentrations of plasma fraction in dams and fetuses (767)
and only increased testes iron contents in another study
59(212) . In zinc-deficient rats intestinal contents of Fe
was found to increase appreciably (761) . It was hypothesized
that iron and zinc are absorbed by different metabolic
pathways and that there is increased turnover of zinc in
iron-deficient rats possibly due to shorted life span or
increased zinc concentration of erythrocytes (764) . Dietary
iron deficiency enhanced absorption of iron and zinc whereas
iron deficiency due to bleeding enhanced the absorption of
iron only (311)
.
INTERACTION BETWEEN COPPER AND IRON:
The first indication of iron-copper interaction
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was demonstrated 60 years ago when copper supplementation
alleviated anemia in iron-supplemented rats (4). Frieden
(768) speculated that copper-dependent anemia is attributed
to subnormal activity of ferroxidase (ceruloplasmin)
resulting in hypoferremia. However, this argument has not
been confirmed by other studies due to the finding that
anemia was absent in rats (400,769) and mice (227,770) when
ceruloplasmin levels were low. A reduction in cytochrome
activity rather than ceruloplasmin was another alternative
explanation for copper-dependent anemia in animals (770)
.
However, Gipp and co-workers (656) demonstrated that the
microcytic hypochromic anemia of high dietary copper was
attributed to impairment of iron absorption and that this
impairment was reversed by ascorbic acid. Weisenberg and
collaborates (402), in contrast, showed that iron
supplementation alleviated anemia in copper-deficient rats
without elevating ceruloplasmin or cytochrome oxidase
activities.
It has been shown that iron is a potent dietary
antagonist of copper metabolism in cattle, and that 250 mg
iron/Kg was adeguate to reduce copper to levels indicative
of copper deficiency (771,772). The reverse was obtained in
experimental rats (773) and that no inhibitory effect was
observed on intestinal copper absorption. Moreover, obvious
hemoglobin response was obtained in rats fed milk-based
diets (774,775) or in copper-deficient suckling mice (40)
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when given iron preparations. It has been demonstrated that
iron-fortified infant formulas were associated with reduced
absorption of copper by 13% and retention by 12% of intakes
(759) . It was revealed that high dietary iron depressed
copper absorption only in copper-deficient rats (776)
.
However, high iron with ascorbic acid caused severe anemia
in copper-deficient rats and decreased plasma ceruloplasmin
by 44% in copper-adequate rats (776) .
On the other hand, dietary copper levels up to 60
ug/g had no effect on liver iron concentrations, but 120
ug/g copper resulted in 50% decrease in liver iron (777)
Iron levels high or less than those recommended by National
research council (30) have been found beneficial to
counteract the adverse effect of high dietary copper on iron
utilization (656,657,778). However, increased dietary copper
was not required upon provision of supplementary iron (656)
High dietary copper could induce a decrease in liver iron,
an increase in liver copper and anemia in pigs (657,779)
indicating interference with iron utilization.
Iron and copper concentrations in liver of rat
tend to decrease with increased dietary supplementation of
respective element (721) . Copper-deficient female rats had
higher serum iron concentrations than copper-deficient male
rats indicating that copper and iron relationships may be
influenced by sex of animal (447) .
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SUGGESTED FUTURE RESEARCH
Within the past several decades many studies have
been conducted to extrapolate trace elements nutritional
risks to human and animal health. Although the advent of
purified diets and the selection of the most relevant animal
model have permitted a new approach to study zinc, copper
and iron, the understanding and detection of nutrient
metabolic and antagonistic effects is far from complete.
Further research is needed to assess zinc status
and adequate dietary intakes in both humans and animals.
More studies should be conducted on factors affecting
bioavailability of zinc. A more detailed study on
metallothionein in relation to zinc, copper and iron may be
of increase value to explain their mutual antagonistic
effects. The biochemical etiology of anorexia and growth
inhibition of zinc deprivation needs to be elucidated. More
biochemical research may be needed to study the influence of
zinc status on impaired brain biochemistry or function as
well as behavior by using appropriate animal models. The
efficacy of therapeutic use of zinc to alleviate toxic
effects of copper, lead, cadmium or calcium is questionable.
The role of zinc deficiency on immune function, pregnancy
and birth defects is in need of determination.
More sensitive devices are needed to detect
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marginal or impaired copper nutrition in human and animal
populations. Further research should be encouraged on the
influence of dietary and endocrine factors on copper
absorption. The growth-stimulating effect of copper is not
fully understood especially for pigs. The precise role of
copper-dependent proteins in detoxification and
bioenergetics require further investigation. There is
evidence of copper-zinc, copper-iron, copper-selenium and
copper-ascorbic acid interactions, but mode of action is
obscured. Studies should be conducted to highlight the role
of lysyl oxidase in sudden infant death syndrome (SIDS) . The
physiological role of copper-dependent proteins including
albocupreins, neurocupreins and diamine oxidases need to be
established. More information is required on the
relationship dietary copper and impairment of carbohydrates
metabolism or inflammations.
Additional research on enhancing or inhibiting
factors of iron are required to understand the intricacies
of availability. The interaction between iron and its
physiological binding proteins as well as other dietary
factors particularly copper, zinc and lead needs to be
clarified. Research on molecular and cellular aspects of
iron metabolism should be promoted to clarify the mechanisms
of absorptions, transport and metabolism. The relationship
between human iron status, behavior and defense mechanism
should be defined. More information is required on the
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cytotoxicity and carcinogenicity of excess iron. More
efficient therapeutic and prophylactic agents should be
sought to improve the treatment of iron-laden patients.
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TRT N WKO WK1 WK2 WK3 WK4 WK5 WK6 WK7 WK8
#
C 1 89.6 125.5 161.1 197.3 228.9 ND ND ND ND
C 2 75.1 100.5 120.8 ND ND ND ND ND ND
C 3 76.2 105.5 144.1 178.5 212.2 231.2 252.3 259.1 268.3
C 4 87.4 122.0 156.2 181.4 215.5 ND ND ND ND
C 5 92.1 123.6 160.1 185.8 220.9 227.4 243.2 245.0 265.4
C 6 87.2 120.8 154.5 180.5 216.1 230.3 240.8 246.8 265.8
C 7 76.8 114.4 143.3 168.3 203.4 214.2 232.0 237.7 246.1
C 8 77.5 112.0 144.7 ND ND ND ND ND ND
C 9 100.6 134.3 170.6 194.9 230.3 345.2 263.8 264.2 280.5
C 10 75.7 110.5 150.5 ND ND ND ND ND ND
C 11 108.1 133.7 169.4 195.8 222.5 ND ND ND ND
C 12 83.9 122.9 160.5 179.6 214.3 231.0 244.0 248.4 260.8
C 13 79.0 99.2 120.0 142.8 161.2 ND ND ND ND
C 14 92.5 122.9 160.5 182.5 213.9 ND ND ND ND
Body Weight/Week of Controls (C)
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TRT N WKO WK1 WK2 WK3 WK4 WK5 WK6 WK7 WK8
#
D 1 94.3 116.6 144.1 155.3 182.2 ND ND ND ND
D 2 83.5 101.8 123.8 132.4 173.2 183.9 190.8 ND ND
D 3 87.9 112.0 112.2 135.6 155.7 ND ND ND ND
D 4 94.7 119.6 ND ND ND ND ND ND ND
D 5 103.9 115.9 125.9 124.8 128.6 125.7 135.0 144.2 158.2
D 6 104.4 123.8 159.3 168.0 193.0 195.8 202.4 201.1 215.7
D 7 81.7 102.9 136.7 158.7 188.6 197.8 199.4 204.5 221.8
D 8 85.5 101.8 111.0 123.2 137.2 ND ND ND ND
D 9 80.6 103.0 124.0 134.3 162.4 164.7 171.8 174.3 194.4
D 10 98.7 118.7 151.7 173.0 200.6 208.5 218.9 228.5 245.5
D 11 76.4 94.4 121.4 125.2 ND ND ND ND ND
D 12 88.1 115.7 150.3 169.0 195.3 188.5 211.9 218.6 247.7
D 13 103.8 121.3 119.5 132.6 136.0 138.4 150.4 158.9 158.2
D 14 77.1 95.1 113.7 145.5 168.0 ND ND ND ND
Body Weight/Week (g) of The Zinc-Deficient Rats (D)
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TRT N WKO WK1 WK2 WK3 WK4 WK5 WK6 WK7 WK8
#
S 1 84.6 122.6 158.6 183.1 217.1 ND ND ND ND
S 2 82.2 118.0 152.7 177.1 207.8 ND ND ND ND
S 3 96.0 124.1 166.1 191.1 220.6 229.5 247.9 245.8 ND
S 4 94.9 133.6 170.2 194.0 231.7 233.1 254.5 253.2 275.5
S 5 90.0 125.1 162.4 184.2 217.8 ND ND ND ND
S 6 91.4 125.7 164.2 181.5 209.0 220.7 229.6 209.0 227.2
S 7 95.4 126.5 162.7 178.4 213.9 221.1 241.8 241.1 264.1
S 8 104.4 124.8 160.6 178.3 210.0 214.3 234.5 235.4 258.2
S 9 91.2 126.6 158.0 177.6 210.7 ND ND ND ND
S 10 85.9 126.8 158.9 181.5 203.4 209.4 226.7 230.6 252.7
S 11 83.2 117.1 153.0 171.9 208.1 220.0 230.8 228.1 244.3
S 12 82.8 103.3 142.9 ND ND ND ND ND ND
S 13 96.3 130.0 160.2 184.2 221.3 232.2 249.4 252.6 276.4
S 14 86.2 120.0 155.4 172.5 205.3 ND ND ND ND
Body Weight (g)/ Week of the Zinc-Supplemented Rats (s)
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TRT NIMA DATE BLOOD
t WEEKS Zn (ppm) Cu (ppm) Fe (ppm)
C 1 4 5.16 0.78 703.58
C 2 2 7.17 0.91 429.92
c 3 2 4.59 0.76 479.17
c 3 6 5.06 1.09 736.08
c 3 8 5.84 0.71 538.50
c 4 4 4.99 0.86 665.94
c 5 6 5.51 1.07 792.77
c 6 2 5.65 0.86 551.45
c 6 6 5.82 1.04 772.13
c 6 8 6.36 0.73 572.58
c 7 8 5.87 0.82 554.71
c 8 2 4.97 0.83 497.10
c 9 6 5.86 0.90 735.21
c 9 8 4.05 0.84 544.32
c 10 2 4.82 0.83 518.86
c 11 4 4.27 0.67 647.82
c 12 2 4.92 0.85 623.01
c 12 6 5.72 0.93 791 .04
c 12 8 7.38 0.80 558.19
c 13 4 4.76 0.74 719.71
c 14 2 5.33 0.93 519.03
c 14 4 5.09 0.83 756.08
Blood Zinc, Copper and Iron Concentrations of the Controls (C)
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TRT ANIMAL DATE BLOOD
# (WEEK) Zn (ppm) Cu (ppm) Fe (ppm)
D 1 4 3.98 0.67 674.08
D 2 6 5.27 0.90 870.14
D 3 2 3.94 0.95 590.40
D 3 4 4.83 1.07 678.83
D 4 2 4.13 0.79 594.72
D 5 6 5.68 0.86 868.92
D 5 8 4.79 0.64 580.76
D 6 6 4.71 0.82 804.35
D 6 8 4.45 0.65 578.14
D 7 2 5.19 0.80 616.22
D 8 2 4.63 0.63 601.69
D 8 4 3.99 0.83 611.62
D 9 6 5.06 0.80 809.69
D 9 3 4.44 0.68 557.62
D 10 8 4.55 0.68 578.68
D 11 2 4.34 0.77 611.04
D 11 4 4.69 1.03 641.94
D 12 2 3.96 0.86 594.36
D 12 6 5.75 0.96 792.36
D 12 8 4.05 0.75 566.89
D 13 2 3.74 0.85 631.28
D 13 8 7.38 0.62 576.19
D 14 4 4.68 0.74 783.01
Blood Concentrations of Zinc, Copper and Iron of the
Zinc-Deficient Rats (D)
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TRT ANIMAL DATE BLOOD
# (WEEK) Zn (ppm) Cu (ppm) Fe (ppm)
S 1 4 5.25 0.77 684.98
S 2 2 5.34 0.93 627.36
s 2 4 5.10 0.93 568.93
s 3 2 5.22 0.81 552.35
s 3 6 5.79 1.04 743.71
s 3 8 5.12 0.73 535.09
s 4 6 5.60 1.02 742.86
s 4 8 5.26 0.69 539.07
s 5 4 5.71 0.69 680.45
s 6 2 6.16 0.77 532.80
s 6 6 5.55 0.92 777.67
s 6 8 4.93 0.82 526.24
s 7 8 4.91 0.94 596.48
s 8 2 7.61 1.00 567.44
s 8 8 4.93 0.75 702.48
s 9 4 5.76 0.75 702.48
s 10 8 5.01 0.76 526.18
s 11 6 5.34 0.94 735.89
s 11 8 5.05 0.90 573.76
s 12 2 5.99 0.70 573.28
s 13 2 7.78 0.88 555.98
s 13 6 5.17 0.97 777.23
s 13 8 5.02 0.80 ND
s 14 2 6.75 0.80 527.26
s 14 4 5.54 0.76 747.01
Blood Concentrations of Zinc, Copper and Iron of the
Zinc-Supplemented Rats (S)
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TRT ANIMAL
#
DATE
(WEEK) LIVER
PROTEIN
KIDNEY
CONTENT [i
SPLEEN HEART LUNG
C 1 4 79.0 63.2 56.2 60.0 48.3
C 3 8 120.2 81.2 62.5 62.1 66.0
c 4 4 78.0 62.5 55.7 60.2 48.7
c 5 8 119.6 82.1 62.3 60.4 60.8
c 6 8 126.3 80.0 65.4 58.7 64.8
c 7 8 121.9 83.2 66.1 59.7 63.1
c 9 8 122.4 80.7 66.0 61.2 66.1
c 11 4 78.5 62.4 54.1 58.6 49.7
c 13 4 80.0 64.0 58.1 58.3 51.2
c 14 4 80.5 60.7 55.1 59.1 52.0
Organ Protein Concentrations of the Controls (C)
224
TRT ANIMAL
#
DATE
(WEEK) LIVER
PROTEIN
KIDNEY
CONTENT
SPLEEN
[mg/g]
HEART LUNG
D 1 4 66.1 52.2 40.7 40.8 30.8
D 3 4 64.3 53.4 44.3 46.1 36.2
D S 8 114.1 70.1 44.6 60.1 66.0
D 6 8 104.7 72.8 48.2 54.5 60.8
D 7 8 108.2 72.3 49.3 48.7 66.2
D 8 4 63.7 50.1 44.1 48.2 33.1
D 10 8 106.2 71.3 45.2 55.7 64.7
D 11 4 63.3 51.7 40.7 44.3 30.1
D 12 8 104.9 70.8 45.5 52.8 64.6
D 14 4 65.2 54.1 41.8 45.3 34.2
Organ Protein Concentrations of the Zinc-Deficient (D)
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TRT ANIMAL DATE
(WEEK) LIVER
PROTEIN
KIDNEY
CONTENT [i
SPLEEN HEART LUNG
S 1 4 77.1 74.1 51.3 56.6 45.8
S 2 4 75.8 72.3 49.8 57.1 44.7
S 3 8 106.2 74.6 51.7 64.0 60.8
s 4 8 1,14.1 78.1 50.6 58.8 66.3
s 5 4 76.3 74.8 50.9 58.1 43.7
s 7 8 112.2 78.0 52.1 54.9 66.2
s 9 4 76.7 73.8 53.1 57.9 44.1
s 10 8 109.3 75.6 48.3 58.2 64.4
s 11 8 110.1 76.3 49.8 57.7 63.7
s 14 4 77.3 73.7 53.4 56.5 44.8
Organ Protein Concentrations of the Zinc-Supplemented Rats (S)
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TRT ANIMAL DATE HEMOGLOBIN HEMATOCRIT
# (WEEK) (9%) (%)
C 1 4 15.3 44.2
c 2 2 14.1 38.2
c 3 2 12.8 35.9
c 3 6 15.9 44.9
c 3 8 15.9 42.1
c 4 4 15.1 41.6
c 5 6 16.9 46.1
c 5 8 17.7 47.9
c 6 2 ND ND
c 6 6 18.3 52.5
c 6 8 ND ND
c 7 8 17.2 46.6
c 8 2 14.1 38.6
c 9 6 16.8 48.2
c 9 8 12.9 37.4
c 10 2 13.6 37.9
c 11 4 16.1 45.5
c 12 2 15.0 42.3
c 12 6 17.9 50.8
c 12 8 18.8 51.3
c 13 4 15.7 42.3
c 14 2 14.9 39.5
c 14 4 17.5 47.4
Hemoglobin Concentrations and Hematocrit Values of the Controls (C)
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TRT ANIMAL DATE HEMOGLOBIN HEMATOCRIT
# (WEEK) (g%) (%)
D 1 4 16.0 45.5
D 2 6 18.9 52.8
D 3 2 15.9 44.3
D 3 4 16.5 45.5
D 4 2 14.9 40.9
D 5 6 19.1 50.7
D 5 8 19.0 50.4
D 6 6 17.9 49.9
D 6 8 18.5 49.0
D 7 2 15.3 42.1
D 7 8 19.0 52.4
D 8 2 14.2 38.4
D 8 4 15.5 41.0
D 9 6 19.5 53.4
D 9 8 17.6 48.6
D 10 8 19.4 52.9
D 11 2 15.4 43.7
D 11 4 17.7 49.1
D 12 2 14.6 40.8
D 12 6 19.4 53.9
D 12 3 18.5 50.4
D 13 2 15.4 41.7
D 13 8 17.4 48.1
D 14 4 17.1 47.0
Hemoglobin Concentrations and Hematocrit Values
of the Zinc-Deficient Rats (D)
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TRT ANIMAL DATE HEMOGLOBIN HEMATOCRIT
# (WEEK) (g%) (%)
S 1 4 15.1 41.2
s 2 2 14.5 39.3
s 2 4 13.4 36.3
s 3 2 14.6 40.0
s 3 6 17.7 49.5
s 3 8 16.5 44.0
s 4 6 16.6 45.8
s 4 8 ND ND
s 5 4 15.2 42.0
s 6 2 14.6 40.4
s 6 6 16.7 45.9
s 6 8 16.3 44.8
s 7 8 15.6 43.0
s 8 2 14.4 38.8
s 8 8 16.1 44.2
s 9 4 15.1 41.3
s 10 8 15.7 42.6
s 11 6 17.6 47.8
s 11 co
eg
15.4
&5s 12 14.0
s 13 2 14.2 39.1
s 13 6 16.7 45.5
s 13 8 15.1 41.0
s 14 2 13.9 38.2
s 14 4 16.4 45.9
Hemoglobin Concentrations and Hematocrit Values
of the Zinc-Supplemented Rats (S)
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TRT ANIMAL DATE ORGAN WET WEIGHT [g]
# (WEEK) LIVER KIDNEY SPLEEN HEART LUNG
c 1 4 8.5 0.80 0.5 0.9 1.3
c 3 8 8.4 0.74 0.7 0.9 1.3
c 4 4 7.7 0.80 0.4 0.8 1.3
c 5 8 6.9 0.86 0.6 0.8 1.2
c 6 8 9.2 0.88 0.5 0.8 1.0
c 7 8 7.2 0.84 0.6 0.8 1.4
c 9 8 8.6 0.94 0.7 0.9 1.8
c 11 4 7.4 0.65 0.5 0.8 1.3
c 12 8 7.5 0.90 0.7 0.9 1.3
c 13 4 6.7 0.65 0.4 0.6 1.0
c 14 4 7.2 0.75 0.5 0.7 1.4
Organ Wet Weight (g) of the Controls (C)
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TRT ANIMAL DATE ORGAN WET WEIGHT [g]
# (WEEK) LIVER KIDNEY SPLEEN HEART LUNG
D 1 4 7.0 0.65 0.6 0.6 0.9
D 3 4 7.2 0.60 0.5 0.6 0.9
D 5 8 4.3 0.56 0.3 0.5 1.0
D 6 8 5.9 0.66 0.3 0.6 0.9
D 7 8 7.3 0.71 0.4 0.7 0.8
D 8 4 5.4 0.50 0.4 0.7 0.8
D 9 8 6.7 0.66 0.3 0.6 0.9
D 10 8 7.8 0.79 0.5 0.9 1.1
D 11 4 4.7 0.55 0.3 0.5 0.8
D 12 8 7.2 0.80 0.4 0.8 1.1
D 13 8 4.5 0.61 0.3 0.6 0.8
D 14 4 6.6 0.50 0.4 0.7 0.9
Organ Wei Weight (g) of the Zinc-Deficient Rats (D)
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TRT ANIMAL DATE ORGAN WET WEIGHT [g]
# (WEEK) LIVER KIDNEY SPLEEN HEART LUNG
s 1 4 9.4 0.75 0.5 0.7 1.0
s 2 4 8.0 0.80 0.5 0.7 1.3
s 3 8 8.7 0.89 0.7 0.7 1.2
s 4 8 8.2 0.87 0.6 0.8 1.2
s 5 4 8.5 0.75 0.4 0.8 1.2
s 6 8 7.3 0.77 0.4 0.6 1.0
s 7 8 9.5 0.70 0.6 0.7 1.1
s 8 8 8.1 0.83 0.5 0.7 1.1
s 9 4 8.4 0.75 0.4 0.8 1.1
s 10 8 6.9 0.72 0.5 0.7 1.1
s 11 8 8.1 0.94 0.5 0.8 1.0
s 13 8 7.5 0.90 0.4 0.7 1.1
s 14 4 7.7 0.70 0.4 0.8 1.1
Organ Wet Weight (g) of the Zinc-Supplemented Rats (S)
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ABSTRACT
Forty-two, male, weanling Sprague-Dawley rats
were divided into three groups of 14 rats each and pair-fed
a purified basal diet containing different zinc
concentrations for 8 weeks. Group C, was fed a control
purified basal diet containing 12 ppm zinc, 5 ppm copper and
35 ppm iron; group D was fed the basal diet containing <2
ppm zinc; group S was fed the basal diet supplemented with
1000 ppm zinc. The effects of the various dietary zinc
concentrations on growth rate, feed efficiency, blood
hemoglobin and hematocrit, relative organ weights, and
protein concentrations of tissues, and the zinc, copper and
iron content of blood, liver, kidney, spleen, heart and lung
were studied. Blood samples were collected at 2,4,6 and 8
weeks and tissues were sampled at 4 and 8 weeks. Rats fed
the zinc-deficient diet (D) had decreased weight gain and
showed signs of zinc deficiency at d 5, but polydipsia and
intermittent mild diarrhoea were also prominent and led to
dehydration. The decreased weight gain in these zinc-
deficient rats (D) suggest decreased protein synthesis may
be of zinc deficiency mediated decreased insulin activity. A
cyclical pattern of decreased and then normal food intake
and weight gain occurred in the zinc-supplemented rats (S)
from weeks 6 to 8 . Copper concentrations increased in heart
and lung by week 4, and decreased in liver and lung at week
8 in the rats of zinc-deficient diet (D) . In rats fed the
zinc-supplemented diet (S) , copper concentrations decreased
in liver and spleen and increased in kidney at week 4, and
decreased in the liver and increased in the heart by week 8.
Tissue iron concentrations in rats on the zinc-deficient
diet (D) were consistently increased in all tissues, except
liver, throughout the study. Rats receiving increased
dietary zinc (S) generally had depressed iron concentrations
in all tissues except heart. The fluctuations in tissues
element concentrations with increased duration of the study
is of variance with previous studies of shorter time frames.
These data suggest an inconsistent antagonism between copper
and zinc or other mechanisms may be involved in copper
homeostasis. If tissue concentrations reflect intestinal
uptake, an apparent competition and/or inhibition occurs
between iron and zinc in the intestine with zinc deficiency
but not in zinc supplementation. The relative dietary
proportions of zinc, copper and iron and time effect
influence zinc, copper and iron metabolism at the intestinal
and cellular transport level.
Keywords:
Zinc, copper, iron, dietary element and interaction,
rats, zinc deficiency, zinc supplementation, weight gain,
feed effeciency, total protein, hemgolobin, hematocrit, oragn
weight, tissue concentrations.
